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1.

LITERATURE REVIEW

1

The word mycotoxin comes from the Greek words myco meaning fungus
and toxicarious meaning poison (Stearn, 2004). Mycotoxins, toxic secondary
metabolites produced by fungi, enter the food chain through feedstuffs (Betina,
1984). The Council for Agricultural Sciences and Technology estimates that
mycotoxins cause economic losses of up to 1.66 billion US dollars per year
(CAST, 2003). Of these fungal toxins, the trichothecene mycotoxin, T-2 toxin, is
among the most virulent (Leeson S. et al., 1995). Although a number of fungal
genera are capable of producing trichothecenes, Fusarium is the most common
(Ueno, 1983). T-2 toxin occurs worldwide, but preferentially grows in cold, wet
climates (Joffe, 1986). However, free trade of cereals and grains among nations
has allowed climatic restrictions of mycotoxins to become obsolete.

T-2 Toxin Structure
Trichothecenes can be divided into two groups: macrocyclic and nonmacrocyclic. All are characterized by a 12,13-epoxytrichothecene
skeleton, and attached side chains differentiate each trichothecene (Bamburg et
al., 1968). The macrocyclic and non macrocyclic mycotoxins are differentiated
by the presence of an ester or ether-ester bridge connecting C-4 and 15 on
macrocyclic type trichothecenes that is absent in non macrocyclic types.
Additionally, non-macrocyclic trichothecenes are divided into 2 subgroups: Type
A and B. In this instance, the structural difference exists in the presence of a
conjugated carbonyl group at the C-8 position on Type B trichothecenes which is
absent in Type A trichothecenes (Leeson et al., 1995). T-2 toxin, 8α-(32

methylbutyryloxy) 4β, 15diacetoxyscirp-9-en-3α-ol, is a non-macrocyclic, type A
trichothecene. Figure 1.1 shows the primary toxic component of T-2 toxin, like
other trichothecenes, is the 12, 13-epoxytrichothecene skeleton followed by a
double bond between C9 and C1 (Grove and Mortimer, 1969). Other examples
of Type A trichothecenes include HT-2 toxin and diacetoxyscirpenol, while Type
B trichothecenes include fusarenone, deoxynivalenol, and nivalenol.
Yoshizawa and coworkers (1980a) described the biotransformation of T-2
toxin in rat liver and the gastrointestinal tract. They found that T-2 toxin was
quickly hydrolyzed to produce HT-2 toxin, which was then hydrolyzed to T-2
tetraol. In vitro trials using protein synthesis inhibition assays showed the toxicity
of T-2 toxin and its derivates are, in order from greatest to least, T-2 > HT-2 > T-2
triol > T-2 tetraol > acetyl T-2 (Thompson and Wannemacher, 1986). Babich and
Borenfreund (1991), using a human hepatoma cell line, found supporting
evidence for this order of toxicity.

Historical Perspective
Mycotoxin poisoning has been documented in humans for centuries. During the
14th, 15th, and 16th centuries in Modern Europe people suspected of being
bewitched, displayed symptoms of tremors, paralysis, spasms, seizures,
permanent muscle contraction, hallucinations, manias, panics, depression and
onset of gangrene. These neurological symptoms are characteristic of ergot
poisoning, a mycotoxin produced by the fungus Claviceps purpurea and suggest
those persecuted as witches might simply have been victims of mycotoxin
3

Double bond
between C9 &
C10

12, 13 epoxytrichothecenering

Figure 1.1 T-2 toxin structure. Toxic components are denoted by the double
bond between C9 and C10, as well as, the 12, 13 epoxytrichothecene ring.
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poisoning (Matossian, 1989; Leeson et al., 1995). Similarly, Schoental (1983),
suggested that Mozart’s death was attributable to mycotoxin exposure due his
poor nutritional status near the end of his life in the 18th century. Schoental
(1980) also proposed that the connection between bowel cancer and beer intake
was due to the use of moldy grains in the production of alcoholic substances.
Specific to T-2 toxicosis: during the 1930s and 1940s the Soviet Union was
affected by Russian Endemic Panmyelotoxicosis. The disease was officially
called Alimentary Toxic Aleukia (ATA; Kimura et al.) and has been associated
with Fusarium infected gain containing T-2 toxin (Mayer, 1953).
ATA is a potentially fatal disease that develops in four stages. The first
stage, showing the caustic nature of T-2 toxin, involves inflammation of the
tissues that come into direct contact with the toxin. Gingivitis, gastritis, glossitis,
and esophagitis ensue, followed by nausea, vomiting, and diarrhea for a period
of three to five days. In the second stage, or incubation phase, symptoms
subside for two to eight weeks depending on individual resistance. During this
time, T-2 toxin exerts a degenerative effect on bone marrow, and eventually
leads to hemorrhagic syndrome, characterized by the appearance of
hemorrhagic spots on the skin. At this point, a transition occurs to the third stage
of marked sickness characterized by complete deterioration of the bone marrow
resulting in agranulocytosis, necrotic angina, hemorrhagic diathesis and sepsis.
Fever develops, necrosis extends the entire length of the gastrointestinal tract,
and lymph nodes swell. If symptoms are diagnosed accurately, death may be
5

evaded. In the period of recovery, or fourth stage, necrotic and hemorrhagic
symptoms may begin to diminish within two weeks, while it may take up to two
months to repair the damage to the bone marrow (Mayer, 1953).

Biochemistry and Metabolism
On the molecular level, T-2 toxin inhibits protein and DNA synthesis
similarly. T-2 toxin’s effect on RNA synthesis is less extreme (Jeffery et al.,
1984). T-2 toxin inhibits proteins synthesis by interacting with peptidyl
transferase located on the 60S ribosomal subunit (Wei et al., 1974). Peptidyl
transferase is responsible for creating the first peptide bond during initiation, but
is also required for all additional steps of elongation (McLaughlin et al., 1977). T2 inhibits each step differently in a dose-dependent manner. At low
concentrations, T-2 will initially stimulate initiation. However, after the first round
of synthesis, further synthesis will be blocked. At high concentrations, T-2 will
terminate all steps of protein synthesis (Murthy et al., 1985).
T-2 exerts additional effects by acting at the cellular level. Cells most
vulnerable to the action of trichothecenes are proliferative cells that contain a
larger number of free polysomes found in their cytoplasmic matrix. Regenerative
tissues of this type include those of hemopoietic organs, lymphoid, intestinal
crypt, and cells in the bursa of Fabricius (Terao, 1983).
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Laboratory Animals
In rodents, a great amount of information is available concerning the
effects of T-2 toxin which has been shown to support cancer growth, and affect
the immune and endocrine systems. Mice fed a diet containing 20μg/g dry diet
for six weeks exhibited reduced growth, reduced food consumption, hypoplasia
of bone marrow and splenic pulp, gastritis, and dermatitis (Hayes et al., 1980).
Carcinogenic and Cytotoxic Activity
In mice, Corrier and Norman (1988) showed carcinogenic effects in
animals intragastrically challenged with T-2 toxin for either 5 days at 2mg/kg
body weight (BW), or once at 4 mg/kg BW. In the following 1 to 2 days post-T-2
toxin challenge, mice were inoculated with tumor cells. T-2 treated mice from
each dosing regime displayed increased frequency of tumor development, as
well as, significantly larger tumors when compared to controls. In a 16 month
study, male mice fed 0, 1.5, or 3.0 parts per million (ppm) T-2 toxin developed
benign pulmonary and hepatic tumors (Schiefer et al., 1987). In other studies,
the liver was predominantly affected, with abnormal changes reported within 24
or 48 hours following oral gavage (2 mg/kg BW T-2 toxin dose; Mollenhauer et
al., 1989). Histological changes were seen intracellularly within the endoplasmic
reticulum heptocytes, necrotic cells within the intestine, and loss of intestinal
microvilli. By day 7, 9, or 12 post-challenge, markedly affected organs were
returning to normal, indicating clearance of the toxin.
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Similar to mice, T-2 toxin has been shown to have carcinogenic and
cytotoxic effects in rats. Schoental and coworkers (1979) reported that rats
developed brain and gastrointestinal tract tumors, cardiovascular lesions, and
gastric hyperkeratosis an average of 22 months after receiving up to 8 once-permonth doses of T-2 toxin (0.2 to 4.0 mg/kg of BW). An in vitro study using lung
tissue, report that 0.1 μM T-2 toxin was cytotoxic to rat alveolar macrophages. T2 toxin reduced cell viability and cell numbers, decreased cell volume, caused
chromium release in a dose dependant manner, and caused morphological
changes that led to cell lysis (Gerberick and Sorenson, 1983). T-2 toxin also
caused lysis of red blood cells. Rat erythrocytes were incubated with increasing
doses T-2 toxin ranging from 2.5x10-4 to 7.5x10-4 M for 4 hours. Results
indicated that T-2 toxin caused hemolysis in a dose dependent manner (Segal et
al., 1983).
Immunological Effects
T-2 toxin has been shown to both enhance and suppress the immune
system. In mice, a single 3mg/kg BW T-2 toxin dose was associated with short
term mastitis resistance after inoculation with pathogenic bacteria. Mastitis
resistance occurred 6 hours after T-2 toxin challenge when mice were inoculated
with Escherichia coli and Staphylococcus aureus (Cooray and Jonsson, 1990). It
was proposed that T-2 toxin stimulated macrophage cells, and caused immune
system activation to fight the infection. However in a long term trial, Tai and
Pestka (1988) showed that administration of T-2 toxin caused decreased
8

resistance in response to Salmonella typhimurium. Increased mortality was
observed in mice first inoculated with Salmonella typhimurium and then treated
with 1 mg/kg BW T-2 toxin every other day for 3 weeks. Cooray and Johnson
(1990) gave a single 3mg/kg BW dose, while Tai and Pestka (1988) challenged
with 1 mg/kg BW every other day for 3 weeks. The levels at which T-2 toxin was
administered, duration of the studies, and whether treatment was either pre or
post-bacterial inoculation contributed to these differences. Since both gram
negative and gram positive bacteria were used, the type of bacteria did not
appear to affect susceptibility.
Decreased resistance of T-2 toxin treated mice to Listeria monocytogenes
was attributed to T-2 toxin’s effect on reducing the population and function of Tlymphocytes and macrophage cells, and subsequent migration into sites of
infection (Corrier and Ziprin, 1987). At low concentrations, T-2 toxin activated
MAPKs (mitogen activated protein kinases) which regulate cell proliferation and
apoptosis (Yang et al., 2000). Activation of immune cell apoptosis by T-2 toxin is
thought to be through up regulation of MAPKs. Similarly, T-2 toxin caused a
suppression of the immune response to viral challenge. Li and coworkers (2006)
used respiratory enteric orphan virus (reovirus) as a model for viral infection.
Balb/C mice were injected intraperitoneally with 1.75 mg/kg BW T-2 toxin and 2
hours later were instilled with intranasal reovirus. T-2 toxin suppressed reovirus
clearance from the lung and increased reovirus-induced pulmonary damage. In
bronchial alveolar lavage fluid (BALF), neutrophil and lymphocyte numbers were
9

elevated on days 3 and 7 following T-2 toxin exposure, but macrophage numbers
were elevated only 7 days post challenge. T-2 also altered cytokine production
in BALF at day 3 and mucosal IgA at days 9-10 post instillation. T-2 toxin
prevented clearance of the virus by suppressing leukocyte numbers, up
regulating interleukin 6 (IL-6) which down regulated IFN-γ (interferon γ), and
down regulated reovirus-specific IgA production. As previously discussed,
Corrier and Norman (1988) suggested that along with the immunosuppressive
effect of T-2 toxin to infectious disease, T-2 toxin could also render animals more
susceptible to tumor growth.

Humans
Due to the lethality of T-2 toxin, little research has been performed in
human subjects. Recently, T-2 toxin along with multiple other mycotoxins, was
found in corn samples in the People’s Republic of China where high instances of
esophageal cancer have been reported (Chu and Li, 1994). Although the
correlation between T-2 toxin exposure and cancer in humans seems unclear,
studies in rodents have reported formation of tumors paralleling T-2 toxin
administration (Schoental et al., 1979; Schiefer et al., 1987). An outbreak of
mycotoxicosis in Kashmir Valley, India in 1987 was traced to trichothecene
containing bread made from moldy grains. Twelve of 24 wheat samples were
found to contain Fusarium mycotoxins and T-2 toxin was found in 5 of the 24
wheat samples. Winter temperatures in India vary from 0 to 25ºC. When this
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was coupled with unseasonal rains in 1987, it allowed for trichothecene growth
and the subsequent outbreak of widespread mycotoxicosis (Bhat et al., 1989).
T-2 toxin has also been found in milk. Milk from Holstein cows treated
with the equivalent of 50 ppm T-2 toxin for 15 days, had detectable
concentrations of T-2 toxin, which was reported to be between 5 to 10 parts per
billion (ppb;Robison et al., 1979a).
Conceivably, indirect exposure to T-2 toxin may occur as a consequence
to consumption of contaminated eggs or organ parts. Chi and coworkers (1978a)
reported toxin passage to the egg in chickens feed a 0.25 mg/kg BW T-2 toxin.
T-2 toxin cleared from within the egg within five days. Additionally, Chi and
coworkers (1978b) found passage into muscle, skin and bile 12 hours following a
0.5 mg/kg BW tritium labeled T-2 toxin dose. The amount of T-2 toxin and its
metabolites present in the muscle estimated by specific radioactivity was 6.7 μg
T-2 toxin per 100 g tissue 12 hours post challenge which is equivalent to 67 ppb.
They estimated that 1 kg muscle would contain 67 μg T-2 toxin and consumption
of this amount T-2 toxin would not cause negative effects (Chi et al., 1977a;
Weaver et al., 1978). These studies show that T-2 toxin can pass into the human
food chain via egg, meat, or milk. Pestka (1995) suggested that human
consumption of mycotoxin contaminated meat was more likely to cause long term
heath problems than acute toxicosis.
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Biological Warfare Agent
Mycotoxins have the dubious distinction of being able to cause large
scale, detrimental effects to humans when used as biological warfare agents
(Stark, 2005). They show potential as warfare agents because once symptoms
of exposure are evident; the avenue of escape is past. Lack of explosion, odor,
or availability of a detection system make mycotoxin intoxication particularly
dangerous (Stark, 2005). Mycotoxin use was suspected during the Middle East
War, Desert Storm. Simon and Rea (2003) used brain imaging to compare
mycotoxin exposed subjects, control subjects, and subjects impaired from
exposure to toxins during Desert Storm. Results showed similarities in brain
scintigrams significant enough to justify further examination. Further
speculations suggest that The Soviet Union used “yellow rain” on the countries of
Afghanistan, Laos, and Cambodia during the cold war, and T-2 toxin has been
implicated as a component of “yellow rain” (Ember, 1984; Wannemacher and
Wiener, 1997) Samples from the environment and victims near the sites of
chemical attacks revealed traces of T-2 toxin (Mirocha et al., 1983). In another
report, T-2 toxin was found in samples of yellow residue scraped from plants
growing near the Phou Bia area in Cambodia in March of 1981 (Rosen and
Rosen, 1982).
Occupational Hazards
T-2 toxin and other mycotoxins pose a threat to agricultural workers who
may be exposed through inhalation of infected grains during harvest and milling.
12

Mycotoxins have been found at levels of 130 ppb in dust particles of corn, and at
higher concentrations in particles of less that 11 μm in diameter (Sorenson et al.,
1981). As discussed earlier, T-2 toxin has been shown to be cytotoxic to rat
alveolar macrophages in vitro (Gerberick and Sorenson, 1983). In vivo, the
toxicity of T-2 toxin has been shown to increase twenty fold when administered to
rats via inhalation verses intraperitoneal administration (Creasia et al., 1990).

Poultry
Poultry suffer some of the greatest losses caused by trichothecene
exposure because of their heightened sensitivity (CAST, CAST, 2003). Chi and
coworkers (1977b) reported the average lethal dose to kill 50% of animals (LD50)
after one exposure was 5.14 mg/kg BW for day old chicks, and 4.97 mg/kg BW
for 8 week old chicks. However, the LD50 for laying hens was 6.27 mg/kg BW T2 toxin showing that young and growing chicks are more sensitive to T-2 toxin
than adult chickens. Other species are similarly affected, with the LD50 values
near that of chickens (Table 1). Bobwhite quail are 3 to 5 fold more resistance to
T-2 toxin than other birds and laboratory animals.
T-2 toxicosis in poultry can be characterized by several physical
symptoms. The first sign of which is oral lesions. Wyatt and coworkers (1972)
observed oral lesions in day old chicks fed diets containing 0, 1, 2, 4, 8, and 16
μg/g diet T-2 toxin. Oral lesions developed within one week and were yellowishwhite in color and caseous in texture. Over the next 2 weeks the oral lesions
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Table 1. 1 LD50 Values of T-2 Toxin for Various Species
Species

LD50 Value (mg/kg)

8-Week Old Broiler Chicks

4.97 Oral (Chi et al., 1977b)

Laying Hens

6.27 Oral (Chi et al., 1977b)

Pigeons

1.7 Oral (Fairhurst et al., 1987)

Bobwhite Quail

14.7 Oral (Kerston, 1998)

Rats

3.71 Oral (McKean et al., 2006)

increased in size and spread over the mouth (Wyatt et al., 1972). Doses of 4, 8,
and 16 μg/g diet induced neural symptoms including abnormal positioning of
wings, hysteroid seizures, and impaired righting reflex in chicks fed T-2 toxin
from 1 day of age (Wyatt et al., 1973). Egg production was also affected by T-2
toxin. Hens fed a diet containing 8 ppm diet T-2 toxin produced fewer eggs with
thinner egg shells. Hatchability of fertile eggs was 20 % less when compared to
controls, and feed consumption was depressed as a result of T-2 toxin
consumption (Chi et al., 1977c).
Chi and coworkers (1978b) challenged broiler chicks orally with 0.5 mg/kg
BW tritium labeled T-2 toxin. Samples taken 0.5 to 48 hours post challenge
showed T-2 toxin present in every tissue sampled 0.5 hours post challenge, with
a subsequent peak at 4 hours except in muscle, skin, and bile which peaked 12
hours following exposure. T-2 toxin was found in the egg twenty-four hours
following challenge with a single 0.25 mg/kg BW tritium labeled T-2 toxin dose.
14

Eggs (yolk and white) were found to contain, 0.7 μg T-2 toxin. In these birds, T-2
toxin cleared from egg white and yolk within five to seven days. In a second
experiment by Chi and coworkers (1978b), birds were challenged 8 consecutive
days with 0.1 mg/kg BW tritium labeled T-2 toxin. Radioactivity within the egg
increased until day 3 and remained at that level until the last dose. T-2 toxin was
found predominantly in the white, but also in the yolk and shell of the egg. In
birds, dosed for 8 consecutive days, T-2 toxin had not completely cleared from
eggs by day 11 following the initial dose (Chi et al., 1978b).
T-2 toxin causes increased mortality in chicks infected with Salmonella.
Chickens were fed 16 μg/g of diet and inoculated with Salmonella. Significantly
higher mortality was observed among birds fed T-2 toxin and inoculated with
Salmonella as compared to those only inoculated with Salmonella (Boonchuvit et
al., 1975). It was proposed that as a consequence of T-2 toxin damage,
Salmonella bacteria were able to infect the gastrointestinal tract easier
(Boonchuvit et al., 1975). These results were supported by Ziprin and Elissalde
(1990). Day old chicks were treated with two daily dose of 2mg/kg BW T-2 toxin.
On day 6 following challenge, chicks were inoculated with Salmonella
typhimurium. A higher rate of mortality was observed among chicks treated with
T-2 toxin and inoculated with Salmonella when compared to Salmonella
inoculated controls.
Spontaneous trichothecene poisoning in birds has been reported. In the
Republic of Croatia, during a particularly humid season in 2002, spontaneous
15

poisoning of Brahma chickens took place (KonjeviÄ‡ et al., 2004). Two of 10
chickens kept as a hobby died as a result of feed contaminated with Fusarium
mycotoxins. Analysis revealed the contaminated diet contained 0.7 mg/kg T-2
toxin, 0.5 mg/kg diacetoxyscirpenol, and an unspecified amount of
deoxynivalenol. Necropsy revealed no oral or esophageal lesions, but
hemorrhages were found in the stomach, as was free blood in the bursa of the
Fabricuis. Histopathologically, necrosis occurred in bursa of the Fabricuis,
stomach, and gut. Once surviving animals were returned to an uncontaminated
diet, symptoms subsided, and no additional deaths occurred.
In a study to determine the effects of trichothecenes on lymphoid cells of
epithelial tissues, and the follicle-associated epithelium of the bursa of the
Fabricius, day old chicks were injected with 5 mg/kg BW T-2 toxin. Chicks were
sacrificed at 15 and 30 minutes post challenge, and then hourly for the next 6
hours. Initially, the central region of the bursal follicle epithelium was disturbed,
and large autophagic vacuoles containing cell debris were found in the cell
cytoplasm. Lipid droplets were found within the Golgi apparatus, necrotic debris
within the intracellular space, and mitochondria were swollen. One and a half
hours after trichothecene administration, degeneration of lymphoid cells began in
the central regions and then extended into the periphery of the lymphoid follicle.
Decreased bursal weight was also observed (Terao et al., 1978)
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Swine
Similar to avians and rodents, pigs intubated with radioactively labeled T-2
toxin showed tissue residues. Following an intubated dose of 0.4 mg/kg BW
tritium labeled T-2 toxin, T-2 toxin residues of 11.5 ppb were found in muscle,
37.7 ppb in liver, and 61.4 ppb in kidney (Robison et al., 1979b). Thus, dissimilar
to the chicken model, the kidney appears to be a primary target of T-2 toxin in
swine.

Cats
Lutsky and Mor (1981) were able to produce the symptoms of Alimentary
Toxic Aleukia in cats using T-2 toxin. Male cats were given gelatinous capsules
containing 0.08 mg/kg BW T-2 toxin every other day until death occurred. Cats
died an average of 20.6 days following their first dose. Symptoms, analogous to
ATA in humans, included leucopenia, hemorrhagic diathesis, agranulocytosis,
bone marrow aplasia, and sepsis. It was concluded, cats could be used as a
model for studying ATA in humans.

Multiple Mycotoxin Exposure
Multiple mycotoxins are often found growing concurrently in the
environment and act together synergistically. Gigeous (1999) showed the
concurrent growth of T-2 toxin and aflatoxin in soybeans grown in Tennessee.
Data from North Vietnam reported corn samples containing both Fusarium and
Asperigillus toxins (Wang et al., 1995). Huff and coworkers (1988) investigated
17

the effects of multiple mycotoxins and reported that dietary T-2 and aflatoxin
have additive effects. Three week old broiler chicks were fed diets containing 4.0
μg/g T-2 toxin, 2.5 μg/g aflatoxin, or both mycotoxins (4.0 μg/g T-2 toxin and 2.5
μg/g aflatoxin). Chicks fed diets containing both mycotoxins showed combined
effects of each individual mycotoxin including decreased BW, increased organ
weight, and decreased corpuscular volume and serum potassium levels. In
another study, chicks were fed a diet containing either 2 mg/kg BW ochratoxin, 2
mg/kg BW T-2 toxin, or 2 mg/kg BW ochratoxin and 4 mg/kg BW T-2 toxin from
one day of age to 3 weeks of age. Ochratoxin and T-2 toxin combined showed
additive effects including decreased BW gain; increased liver, kidney, gizzard,
and proventriculus weight; decreased lactate dehydrogenase activity; and
increased serum triglyceride and gamma glutamyl transferase. Results of this
study indicated that when combined, these two mycotoxins are more toxic than
when consumed individually (Kubena et al., 1988).
Similar to chickens, concurrent exposure to T-2 toxin and B1 Aflatoxin
resulted in additive effects among rats (McKean et al., 2006). Rats were able to
withstand a higher dose of a single mycotoxin than lower doses of two
mycotoxins. Among rats simultaneous dosed with 1.86 mg/kg BW T-2 toxin and
1.36 mg/kg BW B1 aflatoxin, a 70% mortality rate was observed. These values
corresponded to ½ the LD50 value for each individual toxin which was 3.71 mg/kg
BW T-2 toxin, and 2.71 BW mg/kg aflatoxin.
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Mycotoxin Regulation
Acceptable levels of mycotoxins in food and feed grains have been
regulated by various agencies for many years. Currently, 99 countries regulate
mycotoxin levels which is a 30% increase from 1995 to 2003. Fortunately, this
includes about 87% of the world’s population. In the US, the FDA (Food and
Drug Administration) has set maximum allowable mycotoxin levels in feed grains
used for human and animal consumption as shown in Table 1.2 (Egmond and
Jonker, 2004). Note there are no current regulations for T-2 toxin

Detoxification
Different methods for mycotoxin detoxification have been studied,
however little success has been shown. A study was performed using two
mycotoxin binders, 2.5 kg/ton feed of Mycofix™ (Biomin Innovative Animal
Nutrition, Mexico City, Mexico) and 1.5 kg/ton of feed Zeotek™ (Nutek,
Tehuacan, Mexico). Mycofix™ was able to partially protect chickens against
927 ppb T-2 toxin’s detrimental effects as measured by decreased body weight
gain and decreased feed consumption. Zeotek™ proved less effective that
Mycofix™ which was unable to improve body weight gain or feed consumption
among chickens were fed either toxin individually. When 927 ppb T-2 toxin was
combined with 567 ppb ochratoxin, greater detrimental effects were observed,
and neither Mycofix™ nor Zeotek™ alleviated toxic effects. Regardless of binder
inclusion, the combined effects of concurrent exposure to T-2 and ochratoxin was
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Table 1.2 The United States Food and Drug Administrations Regulations for
Mycotoxins in Human and Animal Food
Mycotoxin

Level

Product

Animal type

Aflatoxin M1

0.5 μg/kg

Milk

human consumption

Aflatoxin
B1, B2, G1, and G2

20 μg/kg

all foods except milk

human consumption

300 μg/kg

corn, peanut products, and cottonseed meal

beef cattle, swine and poultry

4000 μg/kg

Whole or partially degermed dry milled

human consumption

Total Fumonisins
(FB1+FB2+FB3)

corn products (e.g., flaking grits, corn grits,
corn meal, corn flour with fat content of
> 2.25%, dry weight basis)
30000 μg/kg

Corn and corn by-products

Breeding ruminants,
breeding poultry including
lactating dairy cattle and
hens laying eggs

Deoxynivalenol

1000 μg/kg

finished wheat products

human consumption

10000 μg/kg

grains and grain byproducts

ruminating beef and
feedlot cattle
(older than 4 months)
and for chickens

Source: (Egmond and Jonker, 2004)
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additive as measured by decreased BW gain, decreased feed consumption,
andblood chemistry (García et al., 2003). Hydrated sodium calcium
aluminosilicate (HSCAS) was fed to day-old male broiler chicks in an attempt to
decrease detrimental effects of 3.5 mg/ kg diet aflatoxins (consisting of 79% B1,
16% G1, 4% B2, and 1% G2 aflatoxin), 8 mg/kg diet T-2 toxin, or 3.5 mg/kg diet
aflatoxins and 8 mg/kg diet T-2 toxin until the age of 3 weeks. HSCAS, at 0.5%,
provided a protective effect against the aflatoxins; however no significant effect
was seen for T-2 toxin as measured by BW gain, oral lesions, and hematology.
HSCAC was able to avert some signs of aflatoxicosis, such increased liver
weight, when aflatoxin was combined with T-2 toxin (Kubena et al., 1990). In a
similar study, Kubena and coworkers (1998) tested the effects of T-BindTM
(another HSCAC compound) at 0.25 or 0.375% diet against 5 mg/kg diet
aflatoxin (consisting of 79% B1, 16% G1, 4% B2, and 1% G2 aflatoxin) or 8 mg/kg
diet T-2 toxin on day-old male broiler chicks. Similar to the 1990 study, T-BindTM
did not protect against T-2 toxin as measured by decreased body weight gain,
decreased efficiency of feed utilization, increased mortality, and increased
occurrence of oral lesions as compared to controls. However, at both dietary
levels of T-BindTM (0.25% and 0.375%) the negative effects of aflatoxin was
reduced. Birds consuming T-BindTM had higher body weight gains and feed
consumption, in addition to, smaller increases in liver, kidney, heart, spleen,
pancreas, and proventriculus organ weight as compared to the aflatoxin only
treated controls (Kubena et al., 1998).
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In pigs, Schell and coworkers (1993) were able to show a protective effect
against some of the negative effects of a diet naturally contaminated with
aflatoxin.

Pigs were fed a diet containing 800 ppb aflatoxin, as measured by

high pressure liquid chromatography (HPLC), and supplemented with various
clays including a palygorskite, a sepiolite, a treated calcium bentonite, or
hydrated sodium calcium alumniosilicate for 4 weeks. Calcium bentonite, at
0.5%, had the greatest effect against 800 ppm aflatoxin. Pigs fed 0.5% calcium
bentonite and aflatoxin improved ADG (average daily gain) and ADFI (average
daily feed intake) when compared to aflatoxin controls in which ADG and ADFI
were both decreased. Eight-hundred ppb aflatoxin increased AST (aspartate
aminotransferase), GGT (gamma glutamyltransferase), and ALP (alkaline
phosphatase) levels. Calcium bentonite, at 0.5%, prevented these increases
when combined with 800 ppb aflatoxin.
Chowdhury and Smith (2005) fed a diet naturally infected with Fusarium
to laying hens for 12 weeks and supplemented it with a 0.2% GMA (polymeric
glucomannan mycotoxin absorbent; Mycosorb, Alltech Inc., Nicholasonville, KY).
Mycotoxin content of the naturally infected diets was analyzed by gas
chromatography and mass spectrometry. Mycotoxins present in the diets
included 12.1 and 11.7 μg/g DON (Deoxynivalenol), 0.5 and 0.4 μg/g 15-acetylDON, and 0.6 μg/g zearalenone in contaminated diets and in contaminated diets
plus GMA respectively. GMA did not prevent decreased feed consumption, but
increased egg production and mass during weeks 4 and 8; increased feed
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efficiency in weeks 8 to 12; and prevented a decrease in plasma glucose
concentrations and amylase activity. The inconsistent increase in egg production
and mass does not point to a true protective effect of GMA, which similarly can
be argued to be correlated with the increase in feed efficiency during weeks 8 to
12.
Superactivated charcoal was not beneficial in protecting growing broilers
against T-2 toxicosis (Edrington et al., 1997). Growing broilers were fed a diet
contaminated with 6 mg/kg BW T-2 toxin and supplemented with superactivated
charcoal for 21 days. Birds challenged with T-2 toxin, despite superactivated
charcoal supplementation, exhibited reduced body weight gain, oral lesions,
reduced feed intake, and changes in hematological parameters.
As previously discussed, T-2 toxin induces PGE2 (prostaglandin E2 )and
fever (Shohami and Feuerstein, 1986). Shohami and coworkers (1987)
attempted to remedy T-2 toxemia with dexamethasone, a cyclooxygenase
inhibitor which interrupts arachadonic acid metabolism to PGE2. Rats were
intravenously dosed with a single 0.55 to 0.75 mg/kg BW T-2 toxin and then
given dexamethasone (2 to 10 mg/kg BW) at 1, 24, and 48 hours post T-2 toxin
challenge. Survival was monitored for 1 week following the initial T-2 toxin dose.
All rats given T-2 toxin alone died within 21 hours of the challenge. However,
only 44% mortality was observed in rats treated with dexamethasone at 1, 24,
and 48 hours post T-2 toxin challenge. Dexamethasone depressed PGE2 levels
6 hours post T-2 toxin challenge, and enhanced survival rates of rats given a
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lethal dose T-2 toxin as defined in this study. Similarly, Tremel and coworkers
(1985) showed reduced mortality among rats pretreated with 1.6 mg/kg BW
dexamethasone and challenged 30 minutes later with 0.75 mg/kg BW T-2 toxin.
Mortality was reduced 40% with dexamethasone pretreatment. Dexamethasone
reduced diarrhea and pulmonary edema, but increased gastrointestinal
hemorrhages.
Probiotics and Mycotoxins
Probiotics have been shown to protect subjects from the toxic effects of
some mycotoxins, and thus have generated interest as a natural product useful
against mycotoxicosis. For six weeks, broilers were fed a diet supplemented with
Eubacterium which is a microbial feed supplement from the bacterial strain BBSH
797. Intestinal tissues of the broilers were protected against 10 mg/kg diet
deoxynivalenol as measured by duodenum and jejunum morphology (Awad et
al., 2006). BBSH 797 has been shown to partially hydrolyze T-2 toxin into HT-2
toxin, a less toxic metabolite of T-2 toxin. Additionally, T-2 tetraol, and
scirpentriol were transformed into their respective, less toxic deepoxy forms
(Fuchs et al., 2002). In vitro studies have shown that a commercially available
probiotic supplement, BioprofitTM, can bind to Aflatoxin B1. In an ex vivo
experiment using avian duodenal tissue, Aflatoxin B1 absorption was slowed but,
not inhibited, by BioprofitTM (Gratz et al., 2005). Agawane and Lonkar (2004)
were able to exhibit a protective effect of a probiotic containing yeast,
Saccharomyces boulardii, on broilers hematobiochemical profile when
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challenged with 0.5 ppm Ochratoxin A (Agawane and Lonkar, 2004).
Supplementation with 10 mg/kg diet Saccharomyces boulardii against 0.5 ppm
ochratoxin A alleviated the decreased values for total proteins, albumin, and
globulin while preventing increases in serum creatinine and serum glutamate
pyruvate transaminase seen in ochratoxin A-only-treated birds.

Increasing T-2 toxin Toxicity
T-2 toxin toxicity may become a larger threat due to pesticide use and the
recycling of poultry litter. The use of organophosphates as pesticides in crop
production may increase the problems associated with T-2 toxin; as they act
through the production of esterase inhibitors which block the normal metabolism
of T-2 toxin and promote hydroxylation instead of hydrolysis of the molecule (Wei
and Chu, 1985). In mice, the LD50 for the hydroxylated form of T-2 toxin, 3hydroxyl T-2 toxin, at 4.63 mg/kg BW, is slightly higher than the LD50 of T-2 toxin,
5.31 mg/kg BW (Yoshizawa et al., 1982). Rat liver homogenates were used to
study the effects of diisopropylfluorophosphate, an esterase inhibiting
organophosphate insecticide (Ohta et al., 1977). Diisopropylfluorophosphate
inhibited the deacetylation of T-2 toxin, thus preventing biotransformation of T-2
toxin to its less toxic derivatives (Thompson and Wannemacher, 1986). As
stated previously, biotransformation of T-2 toxin occurs through hydrolysis to less
toxic derivatives. It follows that T-2 toxin breaks down to the less toxic derivative
HT-2 toxin which breaks down to the less toxic derivative T-2 tetraol (Yoshizawa
et al., 1980a; Thompson and Wannemacher, 1986). Therefore, use of
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insecticides on crops contaminated with T-2 toxin could increase its toxicity by
prevention of the biotransformation into these less toxic derivatives.
Eighty percent of a single dose T-2 toxin will appear in the excreta within
48 hours post challenge, while residues can remain in the tissues for many days
(Chi et al., 1978b; Yoshizawa et al., 1980b). Exposure levels of T-2 toxin or
other mycotoxins may be influenced by management practices. Kuney and
Sangani (2000) reviewed management practices for chickens and determined
that manure removal occurred as often as every 2-3 days to every 2 weeks in
houses with concert floors. However, in houses with dirt floors, manure was
removed only 2-3 times per year (Kuney and Sangani, 2000). T-2 toxin
contamination of manure may accumulate in houses and would be affected by
the frequency of manure removal, and thus increase the exposure risk to resident
birds. Additionally, litter from chicken houses is often used for crop, grass, and
vegetable production (Acosta-Martínez and Harmel, 2006). As a consequence,
T-2 toxin may aerosolize and present exposure issues to humans through
inhalation.
Aside from pesticide use, and recycled poultry litter, temperature has been
shown to affect the toxicity of T-2 toxin. T-2 toxin was found to inhibit the growth
rate of Kluyveromyces marxianus and Saccharomyces cerevisiae at a control
temperature of 30ºC (Gu et al., 1991). Raising the temperature to 40ºC caused a
further reduction in the yeasts’ growth rate which was attributed to T-2 toxin. The
combination of increased temperature and T-2 toxin caused greater detrimental
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effects to the yeast. Joffe (1983) reported that the 1943-1944 winters in
Orenburg, Russia were warmer than average. This increased temperature
coupled with frequent spring freeze thaw cycles contributed to growth of
Fusarium mycotoxins, and led to a large outbreak of Alimentary Toxic Aleukia
(Joffe, 1983). Thus, it is tempting to speculate that global warming could
contribute to the toxicity of mycotoxins. Over the past century, the Earth’s
surface temperature has increased by 0.8°C; 75% of this increase has occurred
over the last 30 years (Hansen et al., 2006). T-2 toxin and other mycotoxins may
pose a greater threat with the promise of a warmer future if coupled with optimal
humidity.

Tri101
In 1998, Kimura and coworkers reported the isolation of trichothecene
biosynthetic gene, tri101, found in Fusarium species. Trichothecene 3-0acetyltransferase, produced by the tri101 gene was primarily responsible for
converting isotrichodermol to isotrichodermin in the T-2 toxin biosynthetic
pathway (Figure 1.2). Disruption of the tri101 gene in Fusarium sporotrichioides
resulted in accumulation of isotrichodermol, and subsequent inhibition of
trichothecene biosynthesis (McCormick et al., 1999). While tri101 has been
proven to be required in T-2 toxin biosynthesis, it has also been shown to be
involved in self defense against T-2 toxin (Kimura et al., 1998; McCormick et al.,
1999). Transformed Schizosaccharomyces pombe cells containing the tri101
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Figure 1.2 Trichothecene biosynthesis (Kimura et al., 1998)
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gene displayed resistance against 100 µg/ml T-2 toxin (Kimura et al., 1998). To
determine the protective mode of action, tri101 was cloned into an expression
vector, transformed into Escherichia coli, and induced to obtain a crude enzyme
fraction. The crude enzyme fraction was incubated with trichothecenes and
acetyl CoA, and the products were analyzed by TLC (Thin Layer
Chromatography) and 1H NMR (Nuclear Magnetic Resonance). It was confirmed
that upon contact with trichothecenes and acetyl coA, the tri101 gene product
acts as a method of self protection by inserting an acetyl group onto carbon-3 of
3-hydroxy trichothecenes (Kimura et al., 1998; Figure 4). An in vitro study using
Newcastle disease virus-infected baby hamster kidney cells was conducted to
measure the effect of trichothecenes on protein synthesis (Kimura et al., 1998).
While it required five fold more 3-O Acetyl T-2 toxin to inhibit protein synthesis,
15 ng/ml T-2 toxin inhibited protein synthesis. Similarly, the 3-acetyl derivatives
of deoxynivalenol, and diacetoxyscirpenol were one third less toxic than the 3hydroxy derivatives. Additionally, protein synthesis was measured in a cell-free
rabbit reticulocyte system. The one-time inhibitory concentration to reduce
protein synthesis by 50% (IC50) for T-2 toxin, DON, and DON fell between 0.3
and 1.2 μg/ml while the IC50 concentrations of the 3-O-acetyl derivatives were
greater than 100 times higher, indicative of reduced toxicity. Tri101 has been
shown to reduce the toxicity of T-2 toxin and other trichothecenes.
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The hypothesis of this research project is that tri101 gene product may
protect avians against T-2 toxin. To test this hypothesis, the objectives of the
reported studies were:
1.) To isolate and purify the tri101 gene product
2.) To test the purified protein in an in vitro system for protective effects
against T-2 toxin
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Abstract
Mycotoxins, toxic byproducts of fungi, represent an annual US agricultural
loss of $500 million to $1.5 billion dollars. Currently there are no feasible
methods to effectively control this problem. T-2 toxin, produced by Fusarium
species, is among the most toxic of mycotoxins. The tri101 gene product, a selfdefense product of Fusarium graminearum, is involved in the biosynthesis of T-2
toxin and converts T-2 toxin to a less toxic intermediate through acetylation at the
3-carbon. The purpose of this research project was to clone the tri101 gene into
an expression vector, pQE30, and purify the gene product. The tri101 gene was
cloned into pQE30 and transformed into JM109 Escherichia coli competent cells.
Sequence analysis confirmed proper ligation of tri101 into the expression vector.
After induction, nitrilotriacetic acid agarose affinity chromatography was used to
purify recombinant Tri101 (rTri101) protein. SDS-PAGE (Sodium Dodecyl Sulfate
Polyacrylamide Gel Electrophoresis) analysis confirmed the presence of a single
50 kDa protein as expected. Purified rTri101 may be used to reduce harmful
effects of T-2 toxin in vitro and in vivo to reduce economic losses due to
trichothecene contamination of feedstuffs.

Introduction
Mycotoxins, secondary metabolites produced by fungi, are mostly
produced by Aspergillus, Penicillium, and Fusarium genus (CAST, 2003). T-2
toxin is a trichothecene mycotoxin produced primarily by Fusarium and grows
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optimally under cold, damp environmental conditions (Lesson, 1995; Joffe,
1983). In humans and animals, symptoms of T-2 toxicosis is characterized by
oral lesions, hemorrhagic lesions of the skin and organs, feed refusal, decreased
body weight gain, and death (Smalley, 1973; Mayer, 1953; Chi et al., 1977a; Chi
et al., 1977b). It is thought that T-2 toxin exerts its detrimental effects by
inhibition of protein synthesis (McLaughlin et al., 1977). In plants, T-2 toxin
causes damage by inhibiting seed germination (Burmeister and Hesseltine,
1970). T-2 toxin had been identified as a biological warfare agent during the
Cold War in southeast Asia (Rosen and Rosen, 1982). Currently, there are no
viable treatments to alleviate problems associated with T-2 toxin exposure.
Fungal species that produce T-2 toxin have developed methods both to
produce toxins and to protect themselves from the toxin (Cundliffe, 1989).
Trichothecene biosynthesis, controlled by genes at 3 loci, include: the main
trichothecene cluster including tri3 through tri14, tri101, and 2 regulatory genes
including tri1 and tri16 (Brown et al., 2003). Self protection lies within the tri101
gene which has been reported in both Fusarium graminerium and Fusarium
sporotrichioides (Kimura et al., 1998a; McCormick et al., 1999). Tri101, involved
in both the production and 3-acetylation of trichothecene mycotoxins, is
responsible for the conversion of isotrichodermol to isotrichodermin, as well as,
the synthesis and acetylation of T-2 toxin, deoxynivalenol, neosolaniol, and 4, 15
diacetoxyscripenol (Figure 1.2; McCormick et al., 1999). Self defense is
achieved by conversion of the 3-hydroxy trichothecenes to 3-O-acetyl derivatives
42

(Kimura et al., 1998a). Protective effects of tri101, tested in vitro by Kimura and
coworkers (1998a), showed that the rTri101 combined with an acetyl source
(acetyl CoA) and the 3-hydroxy form of T-2 toxin, deoxynivalenol, and 4, 15diacetoxyscripenol. Acetylation of T-2 toxin, deoxynivalenol, and 4, 15diacetoxyscripenol was confirmed by thin layer chromatography. Acetyl
derivatives, tested for inhibition of protein synthesis as measured by luciferase
activity in rabbit reticulocytes required a concentration 100 times greater than 3O-hydroxy derivatives. Kimura and coworkers (1998a) also tested the ability of
the trichothecene derivatives to inhibit the growth of yeast, transformed with a
tri101-containing plasmid. Growth of the tri101-containing yeast was not
inhibited by exposure to 3-O-acetyl T-2 toxin whereas exposure to 3-hydroxy T-2
toxin inhibited growth (Kimura et al., 1998a; McCormick et al., 1999).
The discovery of tri101 has lead to in vivo and field studies to reduce the
toxicity of trichothecenes. Tobacco seed germination is inhibited by 4, 15diacetoxyscirpenol. In an attempt to alleviate this problem, tri101-expressing
transgenic tobacco plants were constructed. Upon exposure to 4,15diacetoxyscirpenol, tobacco plants expressing tri101 had a significantly higher
rate of seed germination as compared to controls (Muhitch et al., 2000).
Similarly, transgenic rice plants expressing tri101 were created by Ohsato and
coworkers (2007). Root length, a parameter commonly reduced by
trichothecenes, was measured in controls and tri101 transgenic plants. Tri101expressing rice plants were resistant to 40 µg/ml deoxynivalenol as measured by
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root length. In an attempt to measure a change in toxicity, Manoharan and
coworkers (2006) created transgenic barley plants expressing tri101 and
evaluated accumulation of deoxynivalenol in greenhouse trials. Tri101transformed barley plants grown in a greenhouse were able to reduce the
accumulation of deoxynivalenol, however in field trials, there was no decrease in
deoxynivalenol accumulation in wild verses tri101 expressing transgenic plants
(Manoharan et al., 2006).
To date, no data is available concerning the application of the tri101 gene
product in any animal species. The hypothesis of this study was tri101 gene
product may protect animals against the toxic effects of T-2 toxin in vitro. To test
this hypothesis, the objectives of this study were to:
1.) Clone tri101 gene into expression vector pQE30
2.) Express and purify recombinant Tri101 for in vitro and in vivo studies

Materials and Methods
PCR amplification of tri101 from pUCSVtri101
Plasmid pUCSVtri101 was obtained as a gift from Kimura and coworkers
(1998a). The dried plasmid was reconstituted using 15 μL of distilled, deionized
H20 (ddH20; this sample hereafter called reconstituted pUCSVtri101) and
transformed into JM109 E. coli competent cells (Promega L2001, Madison, WI)
following manufactor’s instructions (Appendix A). Cells were plated on Luria
Bertani (Matossian) agar plates (Fisher, BP 1426-500, Atlanta, GA) containing
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ampicillin at a final concentration of 100 µg/ml (Sigma 0166-5G, St. Louis, MO)
and incubated overnight at 37ºC (Appendix A). To confirm the presence of the
pUCSVtri101 in ampicillin-resistant colonies, DNA was extracted from
representative colonies that were grown overnight at 37ºC in LB media plus 100
µg/ml ampillicin using a QIAprep Spin Miniprep Kit (QIAGEN 27106, Valencia,
CA; (Appendix B). Agarose gel electrophoresis was performed to confirm
isolation of plasmid DNA of the correct size (Appendix C). To prepare a whole
cell sample (JM109 cells containing pUCSVtri101) for pending Polymerase Chain
Reaction (PCR), 2 colonies that were grown overnight at 37ºC in LB media plus
100 µg/ml ampillicin were scraped and placed into 100 μL of distilled, deionized
H20 and boiled for 10 minutes (hereafter called the whole cell sample).
To amplify the tri101 gene, isolated plasmid DNA from pUCSVtri101 was
used as a template in a PCR. The nucleotide sequence as published in
Genbank (accession number AB000874) has a coding sequence of tri101 with
1356 base pairs from codon 135 to 1490. Unique restriction enzymes Bam HI
(Promega, R602A, Madison, WI) and Hind III (Promega R604A, Madison, WI)
were chosen using the NEBCutter website
(http://tools.neb.com/NEBcutter2/index.php; Vincze et al., 2003) and added to
the primers to allow proper orientation during ligation into the expression vector,
pQE30 (QIAGEN 32915, Valencia, CA). Bam HI was incorporated into the 5’end of the forward primer, and Hind III into the 5’-end of the reverse primer for
PCR amplification. Primer design was based on results from the Primer 3 web
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tool (http://frodo.wi.mit.edu/; Rozen and Skaletsky, 2000). Forward primer
sequence was 5’ AAA GGA TCC ATG GCT TTC AAG ATA CAG CTC GAC 3’
and reverse primer was sequence 5’ CCC AAG CTT CTA ACC AAC GTA CTG
CGC ATA CTT 3’ (restriction sites are underlined; Integrated DNA Technologies,
Skokie, IL). The tri101 gene was PCR amplified from both whole cell sample and
from reconstituted plasmid pUCSVtri101 using above primers (Appendix D).
Following the PCR reaction, DNA from both samples was purified using
QIAquick PCR Purification Kit Protocol (QIAGEN 28104, Valencia, CA; Appendix
E). Each purified product was digested with restriction enzymes BamHI and
HindIII (Appendix F). Following digestion, tri101 DNA was purified (Appendix E)
and DNA band size from the 2 samples were compared by agarose gel
electrophoresis (Appendix C).
Ligation of tri101 into expression vector pQE30
Tri101 prepared from the amplified whole cell sample was ligated into the
pQE30 vector (QIAGEN 32915, Valencia, CA; Appendix G1). The resulting
plasmid, pQEtri101, was transformed into JM109 competent cells (Appendix G2).
Twelve transformed colonies were randomly selected from ampillicin resistant
plates and inoculated into 5 mL aliquots of LB broth supplemented with ampicillin
(100 µg/ml final concentration), and grown at 37ºC overnight. Plasmid DNA
from pQEtri101 was extracted using a QIASpin MiniPrep Kit (Appendix B).
Agarose gel electrophoresis was used to confirm DNA from colonies (suspected
to contain plasmid pQEtri101) were larger in size than expression vector, pQE30
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(Appendix C). Sequence analysis was completed at the University of
Tennessee, Knoxville Molecular Biology Resources Facility, and confirmed that
the PCR product had ligated correctly into pQE30 and contained no frameshifts.
Amplification of tri101 from pQEtri101
To confirm that pQEtri101 plasmid transformants contained the tri101
gene of correct size, another PCR amplification was completed. Four test
samples were amplified (Appendix H). Agarose gel electrophoresis confirmed
successful amplification of tri101. To determine if restriction enzymes Bam HI
and Hind III had been correctly incorporated into tri101 by PCR, DNA was
digested (Appendix I) and gel electrophoresis confirmed DNA of correct size.
Expression and Purification of rTri101
Expression
Construct JM109/pQEtri101 cells were grown in 5mL LB media plus
ampicillin (100 µg/ml final concentration; Sigma 0166-5G, St. Louis, MO) and
incubated overnight at 37°C. The following morning, the 5 ml culture was added
into 50mL of 37ºC LB media supplemented with ampicillin (final concentration of
100 µg/ml) and were allowed to grow to an optical density (OD) at 600 nm value
was between 0.5 and 0.7 nm. At this point, a 1 ml sample was taken for sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE; “pre-induction”
sample). The remaining cell culture was induced with 2 mM (final concentration)
Isopropyl-β-D-Thiogalactoside (IPTG). One mL samples were taken every hour
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for 4 hours following addition of IPTG (SDS-PAGE “post- induction” samples).
SDS PAGE (Appendix J) was performed to examine expression of rTri101.
To experimentally check the location of rTri101, it was expressed using a
2 hour induction with IPTG as previously described. After induction, cells were
harvested by centrifugation at 4ºC for 20 minutes at 3800 x g, washed and
resuspended in 5 ml of 1x phosphate buffered saline (PBS; Sigma P5493, St
Louis, MO). Lysozyme (Sigma L3790, St Louis, MO) was added at 1 mg/ml and
cells were lysed by sonication and centrifuged for 30 minutes at 4ºC at 15,000 x
g. SDS PAGE was performed to examine the location of rTri101 either in the
soluble (supernant ) fraction or in the insoluble (pellet) fraction.
To predict the theoretical cellular location of the rTri101 product following
induction and sonication, Signal P (www.cbs.dtu.dk/services/SignalP/) and
TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) web tools were implemented
(Bendtsen et al., 2004; Nielsen et al., 1997; Krogh et al., 2001; Sonnhammer et
al., 1998). The Signal P web tool analyzes properties of amino acids within a
protein sequence to predict the presence or absence of signal peptides. Signal
peptides, comprised of 1 to 12 positively charged amino acids followed by region
of 9 to 14 hydrophobic amino acids, are located near the N-terminal of secretory
proteins (Perlman et al., 1983; von Heijne et al., 1983). TMHMM web tools
analyze the properties of amino acids within a translated protein sequence to
predict the presence or absence of transmembrane regions indicative of cellular
location (Sonnhamer et al., 1998). Transmembrane regions, comprised of an
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expanse of 20 or more hydrophobic amino acids in an α helix, anchor membrane
bound proteins to the lipid bilayer (Nelson and Cox, 2005). Thus proteins
secreted from the cell will have signal peptides, while those which are anchored
in the cell membrane will have a transmembrane region.
Purification of rTri101 from inclusion bodies
For purification of rTri101 from inclusion bodies (with Empigen BB),
QIAGEN’s QIAExpressionist protocol was followed (Appendix K; QIAGEN, 2003).
Elution fractions 2 and 3 of rTri101 purified from inclusion bodies (rTri101 IB)
were combined and confirmed by SDS PAGE (Appendix J). The protein was
dialyzed using a Pierce Slide-A-Lyzer 0.5 to 3 mL Dialysis cassette (Pierce
66370, Rockford, IL; Appendix L) according to protocol. Empigen (final
concentration 1%) was added at this step because rTri101 precipated during
dialysis. After solubilizing, rTri101 IB was sterilized by filtration through a 0.2μm
syringe filter. Relative concentration of 270 µg/ml rTri101 IB was determined by
Pierce BCA protein assay (Pierce 23225, Rockford, IL; Appendix M). Purified
protein was aliquoted into 100 μL fractions and stored at -20ºC.
Purification of rTri101 from soluble fractions
Purification of rTri101 was completed using the soluble fraction (rTri101
SF) following the QIAExpressionist protocol (Appendix N, QIAGEN 2003). SDS
PAGE (Appendix J) confirmed that rTri101 was located in the supernant after
induction and sonication. Eluted fractions 2 and 3 were combined. The
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concentration of 250 µg/ml rTri101 SF was determined by Pierce BCA protein
assay (Appendix M) and stored at -20°C in 5 µL aliquots.
Production of crude enzyme rTri101
The protocol of Kimura and coworkers (1998) was used to produce a
crude enzyme fraction of rTri101 (Appendix O) , and to replicate their
experiments which showed protection of yeast cells against T-2 toxin. Location
of rTri101 in the supernant fraction after sonication and centrifugation was
confirmed by SDS PAGE (Appendix J). . Total protein concentration of 250
µg/ml was determined with the Pierce BCA protein assay (Appendix M) and
stored at -20°C in 5 µL aliquots.

Results & Discussion
Transformation of pUCSVtri101 and amplification of tri101 from
pUCSVtri101
Following transformation of pUCSVtri101 into JM109 cells, plasmid DNA
from transformants showed a band at ~ 5Kb in lanes 2 and 3 which correlated
with the correct size of pUCSVtri101 as published by Kimura and coworkers
(1998a; Figure 2.1). The 3 conformational forms of DNA, supercoiled, nicked
circular and linear, migrate at different rates in agarose gel electrophoresis
(Thorne, 1966; e 1967). If agarose concentration is less than .92%, then
supercoiled will migrat fastest followed by nicked circular, and lastly linear which
migrates slowest (Grossman and Johnson, 1977). The band near 3.5 Kb Figure
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Figure 2.1 Agarose Gel Electrophoresis of plasmid DNA from JM109 cells
transformed with pUCSVtri101. Lane 1- standard marker. Lanes 2 & 3- plasmid
DNA from 2 representative colony transformants.
in 2.1 lanes 2 and 3 was supercoiled form of DNA from plasmid pUCSVtri101
and therefore, migrated further than expected.
Amplification of the tri101 gene from whole cell pUCSVtri101 transformed
JM109 cells produced a band that migrated near the estimated size of tri101 of
1.356 Kb (Figure 2.2, Lane 2)., and agrees reconsistuted pUCSVtri101 product
Kimura and coworkers (1998a; Figure 2.2, Lane 3). From these results, it was
concluded that tri101 had been successfully amplified and transformed into
JM109 cells.
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Figure 2.2 Agarose gel electrophoresis of PCR amplified tri101. Lane 1-standard
marker. Lane 2- PCR amplified DNA from whole cell transformed JM109 cells
containing pUCSVtri101. Lane 3- PCR amplified DNA from reconsistuted
pUCSVtri101 (Kimura et al., 1998a).

Ligation into pQE30 and Transformation of pQEtri101 into JM109cells
Following successful amplification of tri101, the gene was ligated into the
expression vector, pQE30 and retransformed into JM109 cells (Figure 2.3). Gel
electrophoresis of plasmid DNA from the pQE30 vector plus tri101 showed a
band of less than 3 Kb which was less that the expected size of 4.756 of
pQEtri101 (pQE30=3.4 Kb; tri101=1.356 Kb). Similarly, the pQE30 plasmid DNA
migrated to the size analogous with something less than its expected size (3.4
Kb) of about 2 Kb. It is common in agarose gel electrophoresis for plasmid DNA
to migrate further than expected. It was more important that 4 of the colonies
were larger than the pQE30 expression vector control (Figure 2.3, lane
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Figure 2.3 Agarose gel electroporesis pQEtri101 transformed in JM109 cells.
Lane 1- Standard marker; Lanes 2 through 12- Individual, isolated colonies;
Lane 13- Blank; Lane 14- Individual, isolated colony; Lane 15 Control,
expression vector pQE30. * Indicates successfully ligated plasmids. ° Indicates
pQE30 control vector
15). DNA sequence analysis of DNA from Lane 14 confirmed that tri101 had
correctly ligated into pQEtri101 and contained no frame shifts (Figure 2.4).
Amplification of tri101 from pQEtri101
Following DNA sequence analysis of DNA from Lane 14 (Figure 2.4),
plasmid DNA of pQEtri101 from lanes 2, 5, 9, and 14 were further tested by PCR
to verify successful ligation of a product of correct size (Figure 2.5). Agarose gel
electrophoresis showed that each of the pQEtri101 plasmids were correctly
amplified as indicated by their size of 1.356 Kb.
Test for tri101 orientation and activity of restriction enzymes in pQEtri101
To confirm proper orientation of the tri101 gene in the pQE30 expression
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ATAGAGGAGAATTAACTATGAGAGGATCGCATCACCATCACCATCACGGATCCATGGC
TTCAAGATAGGAAGAACACCCTCGGCCAGCTACCAGGCCTCCTTTCGATCTACACCCA
AATCAGTCTCCTCTACCCCGTCTCTGATCCCTCTCAATATCCCACTATTGTCAGCACCT
TCGAGCAAGGTCTTAAGCGCTTCTCCGAAGCCGTCCCATGGGTCGCAGGCCAGGTCA
AAGCCGAGGGCATTAGCGAGGGAAACACGGGAACTTCCTTTATCGTCCCTTTTGAGGA
CGTTCCTCGTGTTGTAGTGAAAGACCTCCGCGATGATCCTTCAGCGCCCACGATCGAG
GGTATGAGAAAGGCGGGATACCCTATGGCGATGTTTGACGAGAACATCATCGCGCCA
AGGAAGACGTTACCTATTGGACCTGGTACTGGCCCCGACGACCCAAAGCCTGTGATTC
TATTGCAGCTCAACTTCATCAAGGGCGGACTCATCCTCACTGTCAACGGACAGCACGG
TGCTATGGATATGGTAGGCCAAGATGCGGTGATCCGTCTACTCTCCAAGGCGTGCCGT
AACGACCCATTCACCGAAGAGGAAATGACGGCCATGAACCTCGATCGCAAGACGATA
GTTCCTTACCTTGAAAACTACACGATTGGCCCCGAGGTAGATCATCAGATTGTCAAACC
TGATGTAGCTGGTGGTGACGCTGTTCTCACGCCGGTCAGTGCAAGCTGGGCGTTCTT
CAATTCAGCCCCAAGGGCATGTCAGAGCTCAGGATGCTGCTACCAAGACTCTTGACGC
ATCAACAAAGTTCGGGTCGACTGACGATGCTCTTTCGGGTTCATCTGGAATCGGCTCT
CGCGTGGTCTCGAAAAAATCGATGGCTCTGCACCTACCGAGTTCTGCCGGCTGTGATG
CTCCACCGGAATGGGGTTTCGAAAAATACCAGGCCTTTTAAAAATGACCTACCAAAGA
CCATTGGGGAATGCCAAGAGTATGGGGAACGGTTCCGCTTTTAAAAATCGACCCGGGA
TGGCAAAAAAAAGGTTGGAGTCTTGCAAACCCAAAGTCAAGTTTTAGGGGGAGGGGAC
CTTTCCCGGTGTGTTTG

Figure 2.4 DNA sequence analysis of tri101 with 6-Histidine tag (outlined with
dashed box), Bam HI (underlined), and Hind III.
vector, DNA was sequenced. Sequence analysis proved correct orientation
(Figure 2.4). To prove that the restriction enzymes were functional, DNA was
digested using restriction enzymes Hind III and Bam HI. In Figure 2.6, samples
in lanes 2, 3, and 5 showed 2 bands 3.4 Kb and 1.4 Kb in size. This was correct
for the expression vector, pQE30 (3.4 Kb) and tri101 (1.4 Kb). In lane 4, a single
band, 5 Kb in size and indicated that only one of the restriction enzymes had
correctly cut the plasmid or that the restriction enzyme sites were non-functional.
Products from lanes 2, 3, and 5 were kept.
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Figure 2.5 Agarose Gel Electrophoresis of PCR DNA from pQEtri101 plasmids.
Lane 1- standard marker. Lanes 2 through 6- PCR products that had indicated
successful ligation of tri101 into pQEtri101

Figure 2.6 Agarose gel electrophoresis of digested pQEtri101. Lane 1 contains
the standard marker. Lanes 2, 3, 4, and 5 contains Hind III and Bam HI digested
plasmids corresponding to lanes 2, 5, 9, and 14 respectively from Figure 2.3.
Note the transformant in lane 4 did not cut successfully.
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Expression and Purification of tri101
Expression
Once it was established that the tri101 gene was of correct size and
sequence, experiments were begun to express the gene. Samples were
collected at 0, 1, 2, 3, and 4 hours post induction with IPTG. The expected size
of rTri101 was 49,600 kilodaltons (kDa; Kimura et al, 1998a). A protein band of
the correct size was observed in the 2, 3, and 4 hour post induction samples
(Figure 2.7

Figure 2.7 SDS PAGE results for rTri101 expression in construct
JM109/pQEtri101. Lane 1- standard marker. Lane 2 - pre-IPTG-induced
sample. Lanes 3, 4, 5, and 6- post-IPTG-induction at 1, 2, 3, and 4 hours post
induction, respectively. Note that maximal induction occurred at greater than 2
hours.
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Purification of rTri101 from inclusion bodies
Induction of the rTri101 in construct JM109/pQEtri101 caused a large
production of protein which was found in the insoluble or pelleted fraction (Figure
2.8). The location of rTri101 in the insoluble fraction was unexpected as Kimura
and coworkers (1998a; 1998b; 2003) and Garvey and coworkers (2007) found
rTri101 in the supernant or soluble fraction. Furthermore, Signal P sequence
analysis did not reveal the presence of a signal peptide (Bendtsen, et al., 2004).
Additionally, the sequence of rTri101 did not contain any largely hydrophobic or
transmembrane regions as determined by TMHMM software (Krogh et al.,
2001;Sonnhamer et al., 1998). Sequence analysis showed rTri101 was cytosolic
and soluble despite its location within the pellet in this study. The fact that
rTri101 was found in the pellet is explained by inclusion bodies (formed by
overexpression of the gene and thus made heavy enough to pellet during
centrifugation). Marston (1986) reported the formation of insoluble aggregates of
protein, called inclusion bodies of during the production of recombinant proteins
in E. coli. To solubilize the rTri101 protein induced by IPTG, a mild detergent
was used. Empigen BB, a mild zwitterionic detergent, was used to break the
inclusion bodies (Lowthert et al., 1995) and was successful as SDS PAGE
showed proteins of the expected size following treatment with Empigen (Figure
2.9). BCA protein assay results indicated that the total protein concentration in
the eluted fractions of rTri101 IB was 270 µg/mL (Table 2.1).
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Figure 2.8 SDS PAGE gel analysis of induction, location, and wash fractions
produced during purification of rTri101 IB. Lane 1- standard marker; Lane 2pre-IPTG-induced sample; Lane 3- post-IPTG-induced sample; Lane 4- total
proteins found within the supernant (soluble) fraction following sonication and
centrifugation; Lane 5- total proteins found within the pellet (insoluble) fraction
following sonication and centrifugation. Lanes 7 through 10- total proteins found
in wash fractions 1 through 4 from the Ni-NTA column (devoid of rTri101).

Figure 2.9 SDS PAGE of eluted rTri101 produced during purification of rTri101
IB. Lane 1- standard marker; Lanes 2 through 6- total proteins contained within
the eluted fractions of rTri101 from the column.
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Table 2. 1 Table 2.1 Total Protein Concentrations of rTri101 under differing
purification schemes
Purification method

Concentration (µg/ml)

rTri101 purified from inclusion bodies

250 μg/ml

rTri101 purified from soluble fractions

270 μg/ml

Crude enzyme fraction rTri101

2044 μg/ml

Purification of rTri101 from soluble fractions
Recombinant Tri101 was purified from soluble fractions (rTri101 SF) which
required induction with a lower concentration of IPTG (1 mM) for a shorter period
of time (2 hour induction period) to both decrease the amount of protein
expressed and to avoid formation of large quantities of inclusion bodies. The
majority of rTri101 was found in supernant fraction which was similar to results
reported by Kimura and coworkers (1998a, 1998b, 2003) and Garvey and
coworkers (2007; Figure 2.10). SDS PAGE showed successful purification of
rTri101 SF (Figure 2.11). The BCA protein assay results indicated that the total
protein concentration in the eluted fractions of rTri101 SF was 250 µg/mL (Table
2.1).
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Figure 2.10 SDS PAGE analysis of induction, location, and wash fractions
produced during purification of rTri101 SF. Lane 1- standard marker. Lane 2total proteins from the pre-IPTG induced cells. Lane 3- total proteins from the
post 1mM IPTG induced cells. Lane 4- total proteins found within the pellet
fraction (containing rTri101) after sonication and centrifugation. Lane 5- total
proteins found within the supernant fraction after sonication and centrifugation.
Lane 6 contains the standard marker. Lane 7, 8, 9, 10, 11, & 12 contain total
proteins from wash fractions of the column devoid of rTri101

Figure 2.11 SDS PAGE of eluted rTri101 SF produced during purification. Lane
1- standard marker. Lane 2- total proteins from the pre-IPTG induced cells.
Lane 3- total proteins from the post 1mM IPTG induced cells. Lane 4- total
proteins from the flow through of the column, which is devoid of rTri101. Lanes
5, 6, 7, 8, 9, & 10- total proteins (including rTri101) from eluted fractions 1-7
respectively
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Production of a Crude Enzyme Protein
A crude enzyme fraction of rTri101 was produced in order to confirm the
work of Kimura and coworkers (1998a), who were able to show protective effects
of rTri101 against T-2 toxin in an in vitro system using yeast cells.

For the

production of a crude enzyme fraction, JM109 cells containing pQETri101 was
induced for 2 hours with 1 mM IPTG. SDS PAGE results indicated the protein
was effectively induced, and located within the supernant (Figure 2.12). The
location of rTri101 in the supernant (soluble) agreed with results previously
reported Kimura and coworkers (1998a; 1998b; 2003) and Garvey and
coworkers (2007). The total protein concentration of the crude enzyme protein

Figure 2.12 SDS PAGE of the crude enzyme fraction of rTri101. Lane 1standard marker. Lane 2- total proteins from the pre-IPTG induced cells. Lane 3
total proteins from 2 hours post IPTG induction of cells. Lane 4- total proteins
found within the supernant after sonication and centrifugation, and is devoid of
rTri101 Lane 5- total proteins found within the pellet fraction after sonication and
centrifugation, and contains rTri101.
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was 2 mg/ml. As expected, this is much higher than either rTri101 IB or SF
isolates because the crude enzyme fraction contained other cellular proteins
(Table 2.1).

Conclusion
Agarose gel electrophoresis confirmed the amplification and ligation of the
tri101 into expression vector pQE30. Successful expression and purification of
rTri101 was achieved from inclusion bodies, soluble fractions and crude
extraction methods. Although the location of rTri101 IB was not as expected;
SDS PAGE analysis of rTri101SF and crude rTri101 showed it to be in the
soluble fraction and agrees with results by Kimura and coworkers (1998a; 1998b;
2003) and Garvey and coworkers (2007). The following in vitro experiments use
each form of rTri101.

.
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3.

IN VITRO STUDIES TO DETERMINE BIOLOGICAL

ACTIVITY OF RECOMBINANT TRI101 SUPPLEMENTED
WITH ACETYL COA ON HD11 CELLS CHALLENGED
WITH T-2 TOXIN
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Abstract
Experiments were conducted to test the protective effects of 3-Oacetyltransferase, the gene product of tri101, against challenge with T-2 toxin in
vitro. Three-O-acetyltransferase was expressed and purified from inclusion
bodies (rTri101 IB), soluble fractions (rTri101 SF), and in a crude enzyme fraction
(crude rTri101). HD11 chicken macrophage cells were incubated with each
isolate of rTri101 and challenged with T-2 toxin. Number of live cells per
treatment were expressed as a percent of controls, set to 100%. Greatest
protective effects of rTri101 were observed from isolates purified from soluble
fractions. At 1nM rTri101 SF, complete protection was observed against 0.1 ppm
(0.2 µM) T-2 toxin (99% rTri101 SF and T-2 toxin verses 54% T-2 toxin alone;
p<0.05). At 2 nM rTri101 SF, partial protection was observed against 0.5 ppm (1
µM) T-2 toxin (83% rTri101 SF and T-2 toxin verses 46% T-2 toxin alone;
p<0.05). Protective effects of rTri101 SF were limited with higher amounts of T-2
toxin, suggesting a threshold for protection. Further studies will be conducted to
test for protective effects of rTri101 SF in vivo.

Introduction
T-2 toxin, a trichothecene mycotoxin grows optimally in cold, wet climates
(Joffe, 1983). During WWII, the population of an entire region of Russia was
nearly destroyed due to Alimentary Toxic Aleukia, a disease caused by T-2 toxin
contamination of grain (Mayer, 1953). A more recent study reported undisclosed
67

amounts of T-2 toxin were found in 20% of 3490 wheat, barley, oat, rye, and corn
samples from the European Union (Schothorst and Egmond, 2004). Similar to
humans, health problems occurred when contaminated grains were fed to
livestock. In particular, poultry exhibited sensitivity to T-2 toxin, and resulted in
physical signs such as oral lesions, neural abnormalities, altered feathering,
decreased weight gain, feed refusal, decreased egg production, and lethargy
(CAST, 2003, Wyatt et al., 1972; Wyatt et al., 1973a; Wyatt et al., 1973b; Wyatt
et al., 1975a; Wyatt et al., 1975b; Chi et al., 1977a; Chi et al., 1977b: Chi et al.,
1977c). T-2 toxin caused immunosuppression rendering birds more susceptible
to disease (Corrier, 1991). Poultry who show physical signs of sickness such as
oral lesions cannot be slaughtered as described by the Poultry Products
Inspection Act (FSIS, 2004), and thus increase monetary losses to producers.
Thompson and Wannemacher (1986) observed that addition of an acetyl
group at C3 of T-2 toxin resulted in a 5 to 100 fold reduction in toxicity. Kimura
and coworkers (1998a) reported tri101 (trichothecene 3-0-acetyltransferase),
found in Fusarium graminearum, was involved in self protection. Tri101
functioned by adding an acetyl group to the C3 position on T-2 toxin, forming 3O-acetyl T-2 toxin. Since then, tri101 has been successfully inserted into
transgenic rice, tobacco, and barley plants (Muhitch et al., 2000; Manoharan et
al., 2006; Ohsato et al., 2007). In each of these studies, tri101 was able to
confer resistance to the plant against trichothecene challenge in laboratory
studies. However, this resistance has yet to be shown in field studies.
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The objective of this study was to investigate the ability of the purified
gene product of tri101 in an in vitro system for protective effects against T-2
toxin. As discussed in chapter 2, rTri101 was purified under native and
denaturing conditions. A third semi purified crude enzyme fraction was also
produced. Each method of purification was examined to determine optimal
conditions to maintain biological activity of rTri101. Experiments were conducted
with HD11 chicken macrophage cells to:
1. Determine the dose of T-2 toxin which caused 50% death of HD11
cells.
2. Test acetyl CoA
A. Determine if acetyl CoA was toxic
B. Determine if acetyl CoA conferred protection against T-2 toxin in
vitro
3. Test rTri101 purified from inclusion bodies (rTri101 IB)
A. Determine if rTri101 (IB) was toxic to HD11 cells.
B. Determine if rTri101 IB conferred protection against T-2 toxin in
vitro when supplemented with acetyl CoA.
4. Test rTri101 SF
A. Determine if rTri101 SF was toxic to HD11 cells.
B. Determine if rTri101 SF conferred protection against T-2 toxin in
vitro when supplemented with acetyl CoA.
5. Test Crude enzyme fraction (CEP) of rTri101
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A. Determine if CEP rTri101 was toxic to HD11 cells.
B. Determine if crude enzyme fraction of rTri101 conferred
protection against T-2 toxin in vitro when supplemented with
acetyl CoA.

Materials and Methods
Maintenance of the HD11 cell line
HD11 chicken macrophage cells (Beug et al., 1979) were maintained in RPMI
1640 media (Sigma R4130, St Louis, MO) supplemented with 5% fetal bovine
serum (FBS; Invitrogen 26170-043, Carlsbad, CA) and 1% antibiotics (Sigma
P4083, St Louis, MO; final concentration 50units/ml penicillin, 0.05mg/ml
streptomycin, and 0.1mg/ml neomycin; hereafter called complete media). Cells
were grown to confluency in a Baxter Ultra Tech incubator at 39ºC with 95% air
and 5% CO2 using Corning 25cm2 tissue culture flasks (Fisher 1012630, Atlanta,
GA). At confluency, cells were manually scraped using a cell scraper (Fisher
087732, Atlanta GA) and transferred to new flasks.
In vitro protocol
For each of the 5 experiments, the following protocol was followed. Cells
near confluency were scraped, pelleted by centrifugation at 50 x g for 2 minutes,
and resuspended in 2 ml of complete media. Cell concentration was calculated
by trypan blue exclusion (Sigma T6146, St Louis, MO) using a 10:1 dilution of
cell suspension to trypan blue. One hundred and fifty thousand cells were plated
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per well into Falcon 48 well plates (0.75 cm2; Beckman Dickinson 3078, Lincoln
Park, NJ) using 750 µL complete media. HD11 cells were allowed to attach for
24 hours, after which, media was removed and replaced with treatments as
described below. In all experiments, cells were incubated with treatments for 18
hours. Following the 18 hour incubation, cells were manually scraped from each
individual well using a 1000 µl pipette tip, pelleted by centrifugation at 14,000 rpm
(16,000 x g) for 18 seconds in a Eppendorf Microcentrifuge 5415C (Fisher 05406-2 Atlanta, GA), resuspended in 500 μL warmed (37ºC) phosphate buffered
saline (PBS; Invitrogen 21600, Carlsbad, CA), repelleted by centrifugation at
14,000 rpm (16,000 x g) for 18 seconds in a Eppendorf Centrifuge 5415C (Fisher
05-406-2 Atlanta, GA), and resuspended in either 100 or 125 μL of PBS. Cells
were immediately counted using trypan blue exclusion at 200x magnification
using a bright field Nikon Eclipse E800 microscope (Marietta, GA). Each
experiment consisted of 3 plates containing 3 replicates of each treatment per
plate (except Experiments 3A and 5A which only consisted of 1 plate containing
2 replicates of each).
Experiment 1. Determine the dose of T-2 toxin which caused 50% death of
HD11 cells
A.

HD11 cells were plated at a density of 150,000 cells per well
and challenged with:
1. 0 pppm T-2 toxin (Sigma 4887, St Louis, MO) in complete
media
2. 0.1 pppm T-2 toxin in complete media
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3. 0.5 pppm T-2 toxin in complete media
4. 1 pppm T-2 toxin in complete media
Experiment 2- Test acetyl CoA
A. Determine if acetyl CoA was toxic to HD11 cells
HD11 cells were plated at a density of 150,000 cells per well
and treated with:
1. 0 μM acetyl CoA (Sigma P2056, St Louis, MO) in
complete media
2. 5 μM acetyl CoA in complete media
3. 10 μM acetyl CoA in complete media
4. 25 μM acetyl CoA in complete media
B.

Determine if acetyl CoA conferred any protective effects
against T-2 toxin in vitro. Four experiments were conducted
to test increasing doses of acetyl CoA for the protective
effects against T-2 toxin. HD11 cells were plated at a
density of 150,000 cells per well and treated with:
Test I- 5µM acetyl CoA verses 0.1 ppm T-2 toxin
1. Complete media
2. 5 µM acetyl CoA in complete media
3. 5 µM acetyl CoA and 0.1 ppm (0.2 µM) T-2 toxin in
complete media
4. 0.1 ppm (0.2 µM) T-2 toxin in complete media
Test II 10 µM acetyl CoA verses 0.5 ppm (1 µM) T-2 toxin
1. Complete media
2. 10 µM acetyl CoA in complete media
3. 10 µM acetyl CoA and 0.5 ppm (1 µM) T-2 toxin in
complete media
4. 0.5 ppm (1 µM) T-2 toxin in complete media
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Test III 25 µM acetyl CoA verses 1 ppm (2 µM) T-2 toxin
1. Complete media
2. 25 µM acetyl CoA in complete media
3. 25 µM acetyl CoA and 1 ppm (2 µM) T-2 toxin in
complete media
4. 1 ppm (2 µM) T-2 toxin in complete media
Experiment 3- Test rTri101 IB
A.

Determine if rTri101 IB was toxic to HD11 cells.
HD11 cells were plated at 150,000 cells per well and
challenged with:
1.
2.
3.
4.

B.

Complete media
1 nM rTri101 IB in complete media
10 nM rTri101 IB in complete media
100 nM rTri101 IB in complete media

Determine if rTri101 IB supplemented with acetyl CoA
conferred any protective effects against T-2 toxin in vitro.
Results from experiment 3A showed that 1nM rTri101 IB was
not toxic. HD11 cells were plated at a density of 150,000
cells per well and challenged with:
1. Complete media
2. 1 nM rTri101 IB plus 5μM acetyl CoA in complete media
3. 1 nM rTri101 IB, 5μM acetyl CoA, and 0.1 ppm (0.2 µM)
T-2 toxin in complete media
4. 0.1 ppm (0.2 µM) T-2 toxin in complete media
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Experiment 4- Test rTri101 SF
A.

Determine if rTri101 SF was toxic to HD11 cells
HD11 cells were plated at 150,000 cells per well and
challenged with:
1. Complete media
2. 1 nM rTri101 SF and 5 µM acetyl CoA, in complete media
3. 2 nM rTri101 SF and 10 µM acetyl CoA in complete
media
4. 5 nM rTri101 SF and 25 µM acetyl CoA in complete
media
B.

Determine if rTri101 SF conferred protection against T-2
toxin in vitro when supplemented with acetyl CoA
Test I. 1 nM rTri101 SF and 5 µM acetyl CoA verses 0.1
ppm (0.2 µM) T-2 toxin
1. Complete media
2. 1 nM rTri101 SF plus 5μM acetyl CoA in complete media
3. 1 nM rTri101 SF, 5μM acetyl CoA, and 0.1 ppm (0.2 µM)
T-2 toxin in complete media
4. 0.1 ppm (0.2 µM) T-2 toxin in complete media
Upon finding protective effects of rTri101 SF, higher levels of
rTri101 SF, acetyl CoA, and T-2 toxin were examined.
Test II. 2 nM rTri101 SF and 10 µM acetyl CoA verses 0.5
ppm (1µM) T-2 toxin
1. Complete media
2. 2 nM rTri101 SF plus 10 μM acetyl CoA in complete
media
3. 2 nM rTri101 SF, 10 μM acetyl CoA and 0.5 ppm (1 µM)
T-2 toxin in complete media
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4. 0.5 ppm (1 µM) T-2 toxin in complete media
Test III. 1 nM rTri101 SF and 5 µM acetyl CoA verses 1 ppm
(2 µM) T-2 toxin
1. Complete media
2. 1 nM rTri101 SF plus 5μM acetyl CoA in
complete media
3. 1 nM rTri101 SF, 5μM acetyl CoA, and 1 ppm (2 µM) T-2
toxin in complete media
4. 1 ppm (2 µM) T-2 toxin in complete media
Test IV. 5 nM rTri101 SF and 25 µM acetyl CoA verses 1
ppm (2 µM) T-2 toxin
1. Complete media
2. 5 nM rTri101 SF plus 25 μM acetyl CoA in complete
media
3. 5 nM rTri101 SF, 25 μM acetyl CoA, and 1 ppm (2 µM) T2 toxin in complete media
4. 1 ppm (2 µM) T-2 toxin in complete media

Experiment 5- Test crude rTri101
A. Determine if crude enzyme fraction of rTri101 was toxic to
HD11 cells. HD11 cells were plated at 150,000 cells per
well and challenged with:
1.
2.
3.
4.

Complete media
0.2 µg/ml crude enzyme rTri101 in complete media
2 µg/ml crude enzyme rTri101 in complete media
20 µg/ml crude enzyme rTri101 in complete media
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B.

Determine if crude rTri101 conferred protection against T-2
toxin in vitro when supplemented with acetyl CoA. HD11
cells were plated at a density of 150,000 cells per well and
challenged with:
1. Complete media
2. 0.2 µg/ml crude enzyme rTri101 plus 5 μM acetyl CoA in
complete media
3. 0.2 µg/ml crude enzyme rTri101, 5 μM acetyl CoA, and
0.1 ppm (0.2 µM) T-2 toxin in complete media
4. 0.1 ppm (0.2 µM) T-2 toxin in complete media

Statistical analysis
Data were analyzed using the MIXED procedure of SAS (SAS, 2006)
using a Randomized Complete Block design. Data were blocked on individual
cell culture plate (random effect). Cell treatments were declared as fixed effects
and the dependent variable was the number of live cells per treatment expressed
as a percent of live control cells set at 100%. Treatment replicates nested within
plate were declared a random effect. Differences between means were
determined using Fisher’s Least Significant Difference test. Significance was
declared at p<0.05.

Results and Discussion
Experiment 1 Determine the dose of T-2 toxin which caused 50% death of
HD11 cells
Incubation of HD11 cells for 18 hours in the presence of 0.1 ppm (0.2 µM)
T-2 toxin, resulted in a 50% reduction in live cells when compared to controls
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(53% live verses 100% live respectively; p<0.05; Figure 3.1). In subsequent
studies, 0.1 ppm T-2 toxin was used to test for protective effects against T-2 toxin
as this amount was similar to environmental levels as reported by Gigeous
(1999). Calvert and coworkers (2005) similarly reported a 50% survival rate of
HEp-2 human epithelial cells following a 48 hour exposure to 200 ng/ml (0.2
ppm) T-2 toxin. Time and dose trials (data not shown) using 4 to 16 ppm T-2
toxin in Phosphate Buffered Saline (PBS) for 3 and 4 hour incubations yielded
unreliable results. It was concluded 18 hour incubations using 0.1 (0.2 µM) to 1
ppm (2 µM) T-2 toxin in complete media gave most consistent and repeatable
data for this study.
Experiment 2 Test acetyl CoA
A.) Acetyl CoA was not toxic to the HD11 cells at any dose tested (5 μM, 10 μM,
and 25 μM; Figure 3.2). The toxicity of acetyl CoA had to be established
because it has been shown to be necessary for activity of 3-O-acetyltransferase
in vitro (Kimura et al., 1998a; Kimura et al., 1998b; Kimura et al., 2003). To
convert T-2 toxin to 3-O-acetyl T-2 toxin, Kimura and coworkers (1998a) used an
approximate ratio of 1:2 T-2 toxin to acetyl CoA (0.4 mM T-2 toxin; 0.8 mM
acetyl CoA) using a crude enzyme rTri101 preparation from Fusarium
graminerium. In other studies, they were able to convert 0.5 mM T-2 toxin to 3O-acetyl T-2 toxin using 1 mM acetyl CoA and crude rTri101 (from Fusarium
sporotrichioides; Kimura et al., 1998b). More recently, Kimura and coworkers
(2003) used this same 1:2 ratio (0.5 mM T-2 toxin; 1 mM acetyl CoA) to convert a
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crude rTri101 preparation (from a Fusarium species that does not produce
trichothecenes) to 3-O-acetyl T-2 toxin. These studies provided evidence that
acetyl CoA was needed in vitro to convert T-2 toxin to the less toxic derivative, 3O-acetyl T-2 toxin.
B.) Protective effects of acetyl CoA against challenge with T-2 toxin were
not found (Figure 3.3). Cell survival when cells were incubated with 0.1 to 1.0
ppm T-2 toxin and 5 to 25 µM acetyl CoA was not different from T-2 toxin
treatments (p>0.05).
Experiment 3 Test rTri101 IB
A.) Recombinant Tri101 IB was purified using a mild detergent, Empigen
BB (Lowhert et al., 1995). Preliminary results (data not shown) using 4 or 20 nM
rTri101 IB with empigen yielded low livability (30% and 35% of control,
respectively). It was suspected that Empigen BB had toxic effects on the HD11
cells, so a dose experiment was performed to determine Empigen BB’s toxicity.
Results (data not shown) indicated that empigen was highly toxic to HD11
chicken macrophage cells at 0.03%, 0.3% and 3% total volume. Therefore,
Empigen BB was removed using Detergent-OutTM kit as described in Chapter 2.
A dose curve of the detergent cleaned rTri101 IB showed it was not toxic at 1 nM
concentration to HD11 cells (Figure 3.4).
B.) Incubation of HD11 cells in the presence of 1 nM rTri101 IB
supplemented with 5µM acetyl CoA did not protect them from challenge with 0.1
ppm (0.2 µM) T-2 toxin (43% verses 100% live respectively; Figure 3.5).
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Figure 3.3 Percent live HD11cells challenged with increasing doses of T-2 toxin and acetyl CoA. Results are
expressed as percent live cells as a percent of control set to 100%. Bars with uncommon letters are different
(p<0.05).

80

120
P ercent of C ontrol

100

100

98
65

80

36

60
40
20
0

Control

1 nM

10 nM

rTri101

rTri101

100 nM
rTri101

Figure 3.4 HD11 cells incubated with increasing dose of rTri101 IB, following the
removal of Empigen BB. Results are expressed as percent live cells as a
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Figure 3.5 Percent live HD11 cells challenged with 0.2 µM T-2 toxin and
supplemented with 1nM rTri101 IB plus 5 µM acetyl CoA. Results are expressed
as percent live cells as a percent of control set to 100%. Bars with uncommon
letters are different (p<0.05).
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However, incubation of HD11 cells with both 1 nM rTri101 IB and 5 µM acetyl
CoA did not prove to be toxic to cells (120% verses 100% live respectively;
p<0.05). Empigen BB has been observed to be capable of solublizing proteins
without altering function (Lowhert et al., 1995). However, during solubilization
the detergent may have changed the structure, so it was no longer biologically
active (Nelson & Cox, 2005). In studies reported elsewhere, T-2 toxin was
converted to 3-0-acetyl T-2 toxin prior to in vitro studies by allowing a 1 hour
incubation at 37ºC with crude rTri101 (Kimura, et al., 1998a). Following
conversion of T-2 toxin to 3-O-acetyl T-2 toxin, both were applied to baby
hamster kidney (BHK) cells and to rabbit reticulocytes in an in vitro translation
system. The 3-O-acetyl derivative was less toxic as measured by protein
synthesis inhibition for both experiments. In this study rTri101, acetyl CoA, and
T-2 toxin prepared in RPMI 1640 complete media were immediately applied to
HD11 cells, and incubated for 18 hours at 39ºC. Possibly, treatments should
have been incubated an hour prior to application to HD11 cells for optimal
protection, and to allow for the acetylation of T-2 toxin. Otherwise, the
BCAprotein assay described in Chapter 2 was performed prior to removal of the
detergent. During the process of Empigen removal, it was possible that the
concentration of rTri101 IB was reduced, resulting in inadequate administration of
rTri101 IB to the HD11 cells when challenged with T-2 toxin.
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Experiment 4 Test rTri101 SF
A.)

HD11 cells were incubated with increasing doses of rTri101 SF. At

concentrations of 2 mM or less, rTri101 SF did not have a cytotoxic effect (Figure
3.6).
B.)

Viability of HD11 cells was protected against T-2 toxin when co-

incubated with rTri101 SF supplemented with acetyl CoA. Percent live cells
treated with 1 nM rTri101 SF plus 5 μM acetyl CoA and challenged with 0.1 ppm
(0.2 µM; Test I) T-2 toxin was not different than control cells (p > 0.05), and was
greater than those incubated with 0.1 ppm (0.2 µM) T-2 toxin alone (p ≤ 0.05;
Figure 3.7). Thus, unlike Experiment 3, 1 nM rTri101 SF supplemented with 5
µM acetyl CoA offered complete protection against 0.1 ppm (0.2 µM) T-2 toxin.
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Figure 3.6 HD11 cells were incubated with increasing dose of rTri101 SF plus
acetyl CoA. Results are expressed as percent live cells as a percent of control
set to 100%.
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expressed as percent live cells as a percent of control set to 100%. Bars with
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At a higher challenge with 0.5 pppm T-2 toxin (Test II) partial protection was
observed with 2 nM rTri101 SF supplemented with 10 μM acetyl CoA (Figure
3.8). Percent live cells challenged with 0.5 ppm (1 µM) T-2 toxin and coincubated with 2 nM rTri101 and 10 µM acetyl CoA was less than controls (83%
live verses 100% live, respectively; p ≤ 0.05) but greater than cells challenged
with 0.5 ppm (1 µM) T-2 toxin challenge alone (83% verses 46% live,
respectively; p ≤ 0.05). Results from this study are encouraging since T-2 toxin
levels used in this study are similar to those found on Ames Plantation (Gigeous
et al., 1999) and indicate rTri101 SF is biologically active.
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Figure 3.8 Percent live HD11 cells challenged with 0.5 ppm (1 µM) T-2 toxin and
supplemented with 2nM rTri101 SF plus 10 µM acetyl CoA. Results are
expressed as percent live cells as a percent of control set to 100%. Bars with
uncommon letters are different (p<0.05).
In test III, HD11 cells were challenged with higher levels of T-2 toxin.
Cells were challenged with 1 ppm (2 µM) T-2 toxin and supplemented with 1 nM
rTri101 SF plus 5 μM acetyl CoA. At this level T-2 toxin (1 ppm), protective
effects of rTri101 SF plus acetyl CoA supplementation (52% live) were not
observed as compared to T-2 toxin alone (47% live; p>0.05; Figure 3.9). To
determine if greater amounts of rTri101 SF were needed for protection at this
level of T-2 toxin, the dose of rTri101 was increased 5 fold to 5 nM rTri101 SF
plus a 5 fold increase in acetyl CoA, 25 μM (Test IV). When combined with 1
ppm (2 µM) T-2 toxin, 5 nM rTri101 SF plus 25 µM acetyl CoA had partial
protective effects against T-2 (66% verses 36% live respectively; p<0.05; Figure
3.10). These results were expected because in Experiment 4A, 5 nM rTri101 SF
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plus 25 µM acetyl CoA was toxic to cells (57% verses 100% live; p<0.05; Figure
3.6). Thus, a threshold must exist for rTri101 SF to confer protection against T-2
toxin on HD11 cells. Binding sites located on rTri101 for trichothecenes as
described by Garvey and coworkers (2007) allow for hydrophobic bonding
between rTri101 and trichothecenes during conversion to less toxic
intermediates. Protective effects of rTri101 may be due to availability of binding
sites and explain the lower level of protection observed in Test IV of this
experiment.
Experiment 5 Test crude rTri101
A.) The final experiment sought to test the effects of a crude enzyme
preparation of rTri101 against T-2 toxin, and to replicate Kimura and coworkers’
(1998) experiment. Increasing doses of crude rTri101 were incubated with HD11
cells. At a total protein concentration of 0.2 μg/ml or less, the enzyme was not
toxic (Figure 3.11). This was not representative of the amount of rTri101, as the
crude preparation included multiple other proteins as was seen in Figure 2.11.
B.) Tests for protective effects of the crude rTri101 showed there was no
protection against 0.1 ppm (0.2 µM) T-2 toxin (Figure 3.12). Cells treated with
0.2 µg/ml crude rTri101 plus 5µM acetyl CoA were not different than controls
(83% verses 100% live respectively; p≥0.05). However when cells were
challenged with 0.1 ppm T-2 toxin and supplemented with 0.2 µg/ml crude
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rTri101 plus 5 µM acetyl CoA, no protection was observed, and percent live was
not different than those challenged with T-2 toxin alone (50% verses 59% live
respectively; p>0.05). Like other bacterial cells, JM109 cells used for the
expression of rTri101 contain lipopolysaccharide (LPS; Amro et al., 2000). LPS
are membrane proteins of gram negative bacterial cell walls which cause an
immune response by up regulating the production of cytokines. LPS causes the
activation of macrophage cells, and the production of nitric oxide which promotes
antimicrobial properties of macrophages and also combines with superoxide
anions to become more potent antimicrobial agents (Holst 1996; Goldsby, et al.,
2003). LPS has been shown to up regulate nitric oxide peritoneal macrophages
from C3H/He and C3H/HeJ mice and in rat Kupffer cells (Steuhr et al., 1985;
Rietschel et al., 1996). In HD11 cells, following an initial endotoxin challenge,
nitric oxide was induced, but in subsequent challenges, nitric oxide was no longer
up regulated indicating a refractory period of endotoxin tolerance (Chang et al.,
1996). Since the crude enzyme fraction in Experiment 5 was not purified, it
contained many proteins, probably including LPS. Thus, when T-2 toxin was
added to cells already activated by endotoxin, additional cell death occurred
because HD11 cells unable to respond to any additional stress (Goldsby et al.,
2003).

Conclusion
Results from these experiments indicate that biologically active rTri101 SF
had significant protective effects against T-2 toxin in vitro. However,
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trichothecene binding sites located on rTri101 may be a limiting factor in
protection against higher amounts of T-2 toxin. Potentially, incorporation of the
isolated gene product in poultry feeds may serve to protect animals against
trichothecene poisoning. Further experiments using rTri101 will determine it’s
ability to provide protection against trichothecene mycotoxins in vivo and may
prove of importance to the poultry industry.

90

References
Amro, N. A., Kotra, L. P., Wadu-Mesthrige, K., Bulychev, A., Mobashery, S., and
Liu, G. Y. (2000). High-resolution atomic force microscopy studies of the
Escherichia coli outer membrane: Structural basis for permeability.
Langmuir 16, 2789-2796.
Beug, H., Vonkirchbach, A., Doderlein, G., Conscience, J. F., Graf, T., and Hr
(1979). Chicken Hematopoietic Cells Transformed by 7 Strains of
Defective Avian Leukemia Viruses Display 3 Distinct Phenotypes of
Differentiation. Cell 18, 375-390.
Calvert, T. W., Aidoo, K. E., Candlish, A. G. G., Fuat, A. R. M., and Tu (2005).
Comparison of in vitro cytotoxicity of Fusarium mycotoxins,
deoxynivalenol, T-2 toxin and zearalenone on selected human epithelial
cell lines. Mycopathologia 159, 413-419.
CAST (2003). Mycotoxins: Risk in Plant and Animal Systems. (A. Council of
Agricultural Science and Technology, IA, Ed.).
Chang, C. C., McCormick, C. C., Lin, A. W., Dietert, R. R., and Sung, Y. J.
(1996). Inhibition of nitric oxide synthase gene expression in vivo and in
vitro by repeated doses of endotoxin. Am J Physiol 271, G539-548.
Chi, M. S., and Mirocha, C. J. (1978c). Necrotic oral lesions in chickens fed
diacetoxyscirpenol, T-2 toxin, and crotocin. Poult Sci 57, 807-808.
Chi, M. S., Mirocha, C. J., Kurtz, H. J., Weaver, G., Bates, F., and Shimoda, W.
(1977a). Subacute toxicity of T-2 toxin in broiler chicks. Poult Sci 56, 306313.
Chi, M. S., Mirocha, C. J., Kurtz, H. J., Weaver, G., Bates, F., Shimoda, W., and
Burmeister, H. R. (1977b). Acute toxicity of T-2 toxin in broiler chicks and
laying hens. Poult Sci 56, 103-116.
Chi, M. S., Mirocha, C. J., Kurtz, H. F., Weaver, G., Bates, F., and Shimoda, W.
(1977c). Effects of T-2 toxin on reproductive performance and health of
laying hens. Poult Sci 56, 628-637.
Corrier, D. E., and Gt (1991). Mycotoxicosis- Mechanisms of
Immunosuppression. Vet. Immunol. Immunopathol. 30, 73-87.
91

FSIS, U. (2004). Poultry Products Inspection Act. Food Safety Inspection
Service, United States Department of Agriculture.
Garvey, G. S., McCormick, S. P., and Rayment, I. (2007). Structural and
functional characterization of the TRI101 trichothecene 3-Oacetyltransferase from Fusarium sporotrichioides and Fusarium
graminearum: Kinetic insights to combating Fusarium head blight. J Biol
Chem.
Gigeous, J. L. (1999). Relationship of late winter precipitation and mycotoxin
development in soybean seeds at Ames Plantation, pp. 71. University of
Tennessee, Knoxville.
Goldsby, R. A., Kindt, T. J., Osborne, B. A., and Kuby, J. (2003). Cells and
Organs of the Immune System. W. H. Freeman and Company, New York.
Holst, O., Ulmer, A. J., Brade, H., Flad, H. D., and Rietschel, E. T. (1996).
Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med
Microbiol 16, 83-104.
Joffe, A. Z. (1983). Environmental conditions conducive to Fusarium toxin
formation causing serious outbreaks in animals and man. Vet Res
Commun 7, 187-193.
Kimura, M., Kaneko, I., Komiyama, M., Takatsuki, A., Koshino, H., Yoneyama,
K., and Yamaguchi, I. (1998a). Trichothecene 3-O-acetyltransferase
protects both the producing organism and transformed yeast from related
mycotoxins. Cloning and characterization of Tri101. J Biol Chem 273,
1654-1661.
Kimura, M., Matsumoto, G., Shingu, Y., Yoneyama, K., and Yamaguchi, I.
(1998b). The mystery of the trichothecene 3-O-acetyltransferase gene.
Analysis of the region around Tri101 and characterization of its homologue
from Fusarium sporotrichioides. FEBS Lett 435, 163-168.
Kimura, M., Tokai, T., Matsumoto, G., Fujimura, M., Hamamoto, H., Yoneyama,
K., Shibata, T., and Yamaguchi, I. (2003). Trichothecene nonproducer
Gibberella species have both functional and nonfunctional 3-Oacetyltransferase genes. Genetics 163, 677-684.
Lowthert, L. A., Ku, N. O., Liao, J., Coulombe, P. A., and Omary, M. B. (1995).
Empigen BB: a useful detergent for solubilization and biochemical analysis
of keratins. Biochem Biophys Res Commun 206, 370-379.
92

Manoharan, M., Dahleen, L. S., Hohn, T. M., Neate, S. M., Yu, X. H., Alexander,
N. J., McCormick, S. P., Bregitzer, P., SchwarZ, P. B., and Horsley, R. D.
(2006). Expression of 3-OH trichothecene acetyltransferase in barley
(Hordeum vulgare L.) and effects on deoxynivalenol. Plant Science 171,
699-706.
Mayer, C. F. (1953). Endemic panmyelotoxicosis in the Russian grain belt. I. The
clinical aspects of alimentary toxic aleukia (Kimura et al.); a
comprehensive review. Mil Surg 113, 173-189.
Muhitch, M. J., McCormick, S. P., Alexander, N. J., and Hohn, T. M. (2000).
Transgenic expression of the TRI101 or PDR5 gene increases resistance
of tobacco to the phytotoxic effects of the trichothecene 4,15diacetoxyscirpenol. Plant Science 157, 201-207.
Nelson, D. L., and Cox, M. L. (2005). The Three-Dimensional Structure of
Proteins. W. H. Freeman and Company, New York.
Ohsato, S., Ochiai-Fukuda, T., Nishiuchi, T., Takahashi-Ando, N., Koizumi, S.,
Hamamoto, H., Kudo, T., Yamaguchi, I., and Kimura, M. (2007).
Transgenic rice plants expressing trichothecene 3-O-acetyltransferase
show resistance to the Fusarium phytotoxin deoxynivalenol. Plant Cell
Rep 26, 531-538.
Rietschel, E. T., Brade, H., Holst, O., Brade, L., Muller-Loennies, S., Mamat, U.,
Zahringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A. J.,
Mattern, T., Heine, H., Schletter, J., Loppnow, H., Schonbeck, U., Flad, H.
D., Hauschildt, S., Schade, U. F., Di Padova, F., Kusumoto, S., and
Schumann, R. R. (1996). Bacterial endotoxin: Chemical constitution,
biological recognition, host response, and immunological detoxification.
Curr Top Microbiol Immunol 216, 39-81.
SAS Institute Inc. (2006). SAS for Windows Service Pack 9.1.3, Cary, NC.
Schothorst, R. C., and van Egmond, H. P. (2004). Report from SCOOP task
3.2.10 "collection of occurrence data of Fusarium toxins in food and
assessment of dietary intake by the population of EU member states".
Subtask: trichothecenes. Toxicol Lett 153, 133-143.
Stuehr, D. J., and Marletta, M. A. (1985). Mammalian nitrate biosynthesis: mouse
macrophages produce nitrite and nitrate in response to Escherichia coli
lipopolysaccharide. Proc Natl Acad Sci U S A 82, 7738-7742.

93

Thompson, W. L., and Wannemacher, R. W., Jr. (1986). Structure-function
relationships of 12,13-epoxytrichothecene mycotoxins in cell culture:
comparison to whole animal lethality. Toxicon 24, 985-994.
Wyatt, R. D., Hamilton, P. B., and Burmeister, H. R. (1975a). Altered feathering
of chicks caused by T-2 toxin. Poult Sci 54, 1042-1045.
Wyatt, R. D., Doerr, J. A., Hamilton, P. B., and Burmeister, H. R. (1975b). Egg
production, shell thickness, and other physiological parameters of laying
hens affected by T-2 toxin. Appl Microbiol 29, 641-645.
Wyatt, R. D., Colwell, W. M., Hamilton, P. B., and Burmeister, H. R. (1973a).
Neural disturbances in chickens caused by dietary T-2 toxin. Appl
Microbiol 26, 757-761.
Wyatt, R. D., Hamilton, P. B., and Burmeister, H. R. (1973b). The effects of T-2
toxin in broiler chickens. Poult Sci 52, 1853-1859.
Wyatt, R. D., Weeks, B. A., Hamilton, P. B., and Burmeister, H. R. (1972).
Severe oral lesions in chickens caused by ingestion of dietary fusariotoxin
T-2. Appl Microbiol 24, 251-257.

94

4.

Conclusion
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The goals of this study were to produce and isolate the tri101 gene
product, trichothecene-3-O-acetyltransferase (rTri101). Further, the aim was to
determine if tri101 conferred protective effects against T-2 toxin on HD11 chicken
macrophage cells. Experiments were performed in different chronological order
than presented in this thesis. Recombinant Tri101 IB was produced first and in
vitro experiments were conducted on it’s in vitro protective effects. When rTri101
IB proved unsuccessful, crude rTri101 was produced similar to the protocol
published by Kimura and coworkers (1998). Crude rTri101 was also observed not
to confer protective effects in vitro. Lastly, rTri101 SF was produced. In vitro
experiments determined that some levels of therTri101 SF conferred protective
effects against T-2 toxin. The protective effects were greatest with the ratio of
rTri101 to T-2 toxin was 1:200.
T-2 toxin interacts with peptidal transferase and exerts its detrimental
effects by inhibiting protein, DNA, and RNA synthesis (Wei et al., 1974). For this
reason, T-2 toxin affects rapidly dividing cells such as those of the intestines,
spleen, thymus, testes, and lymphatic system (Ueno, 1977). HD11 chicken
macrophage cells were therefore well suited to test for protective effects against
T-2 toxin. Poultry are sensitive to T-2 toxin. Symptoms of T-2 toxicosis in poultry
include oral lesions, neural abnormalities, altered feathering, decreased body
weight gain, and decreased egg production (Wyatt et al., 1972; Wyatt et al.,
1973a; Wyatt et al., 1973b; Wyatt et al., 1975a; Wyatt et al., 1975b). Numerous
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attempts have been made to alleviate the effects of T-2 toxin in chickens
(Chowdhury and Smith, 2005; García et al, 2003; Kubena et al., 1998; (Kubena
et al., 1990). However, none have been successful.
Tri101 may be the solution to the T-2 toxin problem. Tri101 reduces the
toxicity of T-2 toxin by inserting an acetyl group on C3. It was speculated the
addition of this acetyl group changed the spatial arrangement of T-2 toxin's the
most toxic component, the 12, 13 epoxytrichothecene ring (Grizzle, 2007;
Bamburg et al., 1968). Therefore, T-2 toxin was rendered less toxic. The
purification of rTri101 is only the first step in the long pathway to produce a feed
additive or drug that may reduce the toxicity of T-2 toxin. Recombinant Tri101
protected HD11 cells against T-2 toxin. If rTri101 is successful in vivo, there are
possibilities for its use as a therapeutic drug. Since the approval of the first
recombinant protein therapeutic drug, Humulin, in 1982, 40 recombinant proteins
have been approved for therapeutic use in the US (Reichert, 2003). In 2003,
estimates quoted recombinant DNA technologies to represent over $32 billon
dollars in the human medical biotechnology industry. This estimate is expected to
grow larger by 2010 (Pavlou & Reichert, 2004). Recombinant Tri101 may
ultimately serve as safe, non-invasive method to effectively control the
detrimental effects of mycotoxins for humans and animals.
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Appendix A
JM109 Competent Cell Transformation Protocol

Materials

JM109 Competent Cells (Promega L2001, Madison WI)
SOC medium
LB plates with antibiotic
Falcon 17 × 100mm polypropylene culture tubes (Fisher 14-959-10B,
Atlanta GA)
Bacto®-tryptone (BD Biosciences, 211705)
Bacto®-yeast extract (BD Biosciences 210929)
Ampicillin (Sigma A0166-5G); made into 50 µg/ml stock
AccuSpin MicroR MicroCentrifuge (Fisher, 13100511)
Glucose (Sigma G5767, St Louis, MO)
Petri Dishes (Fisher 0875712, Atlanta, GA)
LB Agar (Fisher BP1425-500 Atlanta, GA)
42°C gyratory water bath

Solutions

Glucose, 2M
Weigh 180.16g glucose (C6H12O6; F.W. 181.16)
Add distilled water until final volume is 500ml
Filter-sterilize through a 0.2µm filter unit
Store in aliquots at -20°C.
50 mg/ml Ampicillin Stock
Measure 0.5 g Ampillicin
Add to 10 ml ddH20
Vortex until completely mixed
Filter-sterilie through a 0.45 µm filter unit
Store in 1 ml aliquots at -20ºC
LB Agar plates supplemented with Ampicillin
500 mL dd H20
20 g LB Agar
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Autoclave for 20 minutes
Cool to 55ºC
Add 1 ml of 50 mg/mL Ampicillin stock
Pour plates
Mg2+ stock solution, 2M
Weigh 101.5g MgCl2
Weigh 123.3g MgSO4
Combine and Add distilled water until final volume is 500ml
Fillter-sterilize through a 0.2µm filter unit.
SOC medium
2.0g Bacto®-tryptone
0.5g Bacto®-yeast extract
1ml 1M NaCl
0.25ml 1M KCl
1ml Mg2+ stock, filter-sterilized
1ml 2M glucose, filter-sterilized
Bring to 100ml volume with distilled water.
Add Bacto®-tryptone, Bacto®-yeast extract, NaCl and KCl to 97ml distilled water.
Stir to dissolve. Autoclave and cool to room temperature. Add 2M Mg2+ stock
and 2M glucose stock, each to a final concentration 20mM adjust pH to 7.0.
Filter the complete medium through a 0.2µm filter unit.
Procedure

1. Chill sterile 17 × 100mm polypropylene culture tubes on ice, one per
transformation (e.g., Falcon. 2059).
2. Remove frozen Competent Cells from -70°C and place on ice for 5 minutes, or
until just thawed. Once the cells have thawed, pipet quickly or use chilled (4°C)
pipette tips to prevent the cells from warming above 4°C.
3. Gently mix the thawed Competent Cells by tapping the tube, and transfer
50 µl to the chilled culture tube.
4. Add 1 µl pUCSVTri101 (the concentration was unknown) to 50 µl of
Competent Cells. Move the pipette tip through the cells while dispensing.
Quickly mix the tube by tapping the side.
5. Immediately return the tubes to ice for 10 minutes.
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6. Heat-shock the cells for exactly 45 seconds in a water bath at exactly 42°C.
Do not shake.
7. Immediately place the tube on ice for 2 minutes.
8. Add 950µl of cold (4°C) SOC medium to each transformation reaction, and
incubate for 90 minutes at 37°C with shaking (approximately 225rpm).
9. For each transformation reaction, it was recommend diluting the cells 1:10 and
1:100 and plating 100µl of the undiluted, 1:10 and 1:100 dilutions on antibiotic
plates. Incubate the plates at 37°C for 12-14 hours.
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Appendix B
Plasmid DNA Purification Using the
QIAprep Spin Miniprep Kit
Materials

LB Broth (Fisher BP1426-500 Atlanta, GA)
Ampicillin (Sigma A0166-5G); made into 50 µg/ml stock
AccuSpin Micro R MicroCentrifuge (Fisher, 13100511 Atlanta, GA)
1.5 ml Eppendorf tubes (Fisher 05408429 Atlanta, GA)
QIAprep Spin Miniprep Kit (QIAGEN, 27106 Valencia, CA) contains:
Buffer P1
Buffer P2
Buffer N3
Buffer PB
Buffer PE
Buffer EB
LyseBlue
RNase A
2 ml collection tubes
Solutions
LB Broth
500 mL dd H20
12.5 g LB Broth (powder)
Autoclave for 20 minutes
Cool to 55ºC
Add 1 ml of 50 μg/mL Ampicillin (final concentration 100 µg/ml)
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Procedure
1. Grow transformed JM109 cells containing pUCSVtri101 in LB plus ampillicin
media overnight at 37ºC in a shaking water bath. Remove 1 ml of overnight
culture. Centrifuge at 13,000 rpm (16,000 x g) for 1 minute at room temperature.
2. Resuspend pelleted bacterial cells in 250 μl Buffer P1 and transfer to the
microcentrifuge tube.
3. Add 250 μl Buffer P2 and mix thoroughly by inverting the tube 4–6 times.
Mix gently by inverting the tube. Do not vortex.
4. Add 350 μl Buffer N3 and mix immediately and thoroughly by inverting the tube
4–6 times.
5. Centrifuge for 10 minutes at 13,000 rpm (~16,000xG) in a table-top
microcentrifuge.
6. Apply the supernatants from step 4 to the QIAprep spin column by decanting
or pipetting.
7. Centrifuge at 13,000 RPM (~16,000 x g) for 30–60 seconds. Discard the flowthrough.
8. Wash the QIAprep spin column by adding 0.5 ml Buffer PB and centrifuging
at13,000 RPM (~16,000 x g) for 30–60 seconds Discard the flow-through.
9. Wash QIAprep spin column by adding 0.75 ml Buffer PE and centrifuging at
13,000 RPM (~16,000 x g) for 30–60 seconds
10. Discard the flow-through, and centrifuge at 13,000 RPM (~16,000 x g) for an
additional 1 minute to remove residual wash buffer.
11. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute
DNA, add 50 μl H20 to the center of each QIAprep spin column, let stand for 1
minute, and centrifuge at 13,000 RPM (~16,000 x g)for 1 minute.
Note: All protocol steps should be carried out at room temperature.
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Appendix C
Gel Electrophoresis
Materials

Agarose Gel (Fisher BP1356-500, Atlanta, GA))
1Kb Ladder (Promega G571A, Madison, WI)
Blue Orange 6x Loading Buffer (Promega G190A, Madison, WI)
50x Tris/Acetic Acid/EDTA (TAE) Buffer (BioRad 161-0743, Hercules, CA)
10 mg/ml Ethidium Bromide (BioRad 161-0433; Hercules, CA; wear gloves
because Ethidium Bromide is a carcinogen)
Alpha Innotek FluorChemTM 5500 (AlphaInnoTek 5500, San Leandro, CA)
Solutions

1x TAE Buffer
Mix 49 parts water with 1 part 50X TAE Buffer (final concentration will be
40 mM Tris, 20 mM acetic acid, and 1 mM EDTA (pH 8.0))
Procedure

For an 0.8% concentration:
1. Measure 50 mL 1X TAE Buffer into a 125 mL glass bottle
2. Measure 0.4 g Agarose and add to 1X TAE buffer
3. Place in Microwave for 1 minute
a. Watch solution to ensure that it does not boil over
4. Allow solution to cool on bench for 2-3 minutes
5. Add 5 μl of 10 mg/ml Ethidium Bromide
6. Mix solution by swirling
7. Pour slowly into gel tray
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8. Add comb
9. Wait 15-20 minutes for gel to become firm
10. Release gel from vice
11. Place tray in electric field filled with 1X TAE buffer
12. Ensure gel is completely covered with 1X TAE buffer
13. Load reagents
a. Load 5 μl of the 1 Kb ladder
b. Mix 5 μl of each sample to 1 μl of Blue Orange 6x Loading Buffer
14. Place electrodes onto apparatus (positive to positive and negative to
negative) so DNA will migrate toward the positive (red) node
15. Run gel100 volts of constant voltage for 30 minutes
16. Remove electrodes from apparatus
17. Remove gel
18. Take picture using transilluminating filter of the Alpha Innotek FluorChem
5500
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Appendix D
PCR Reaction with pUCSVtri101
Materials
Forward primer (Integrated DNA Technologies, Skokie, IL)
Reverse primer (Integrated DNA Technologies, Skokie, IL)
Distilled, deionized H20
Taq DNA polymerase 10x Reaction Buffer without MgCl2 (Promega
M190G, Madison, WI)
MgCl2 (Promega A351H, Madison, WI)
dNTP (Promega C114G, Madison, WI)
Taq DNA Polymerase in Storage Buffer B (Promega M166B, Madison,
WI)
0.2 ml PCR Tubes (Fisher E0030 124 260, Atlanta GA)
Eppendorf Mastercycler (Fisher S65955, Atlanta GA)
Solutions
Reaction consisted of:
5 μL whole cell pUCSVtri101 (unknown concentration)
4 μL 5 pM/µl forward primer
4 μL 5 pM/µl reverse primer
64 μL distilled, deionized H20
10 μL Taq DNA Polymerase 10x Reaction Buffer without MgCl2
10 μL MgCl2 (final concentration 1.5 mM)
2 μL dNTP
1 μL Taq DNA Polymerase in Storage Buffer B
100 μL
5 μL reconstituted pUCSVtri101 (unknown concentration)
4 μL 5 pM/µl forward primer
4 μL 5 pM/µl reverse primer
64 μL distilled, deionized H20
10 μL Taq DNA Polymerase 10x Reaction Buffer without MgCl2
10 μL MgCl2 (final concentration 1.5 mM)
2 μL dNTP
1 μL Taq DNA Polymerase in Storage Buffer B
100 μL
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Procedure

Thermocycler settings started with 5 minutes at 95ºC then 33 repetitions
of rotating intervals of 30 seconds at 95ºC to denature, 30 seconds at 55ºC to
anneal, and 90 seconds at 72ºC for extension
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Appendix E
QIAquick PCR Purification Kit Protocol
Materials

AccuSpin MicroR Microcentrifuge (Fisher, 13100511, Atlanta, GA)
QIAquick PCR Purification Kit (QIAGEN, 28106 Valencia, CA) contained:
QIAquick Spin Columns
Buffer PBI
Buffer PE (concentrate)
Buffer EV
2 ml collection tubes

Procedure

1. Add 500 µl of Buffer PBI to 100 µl of the PCR sample and mix.
2. Check that the color of the mixture is yellow (similar to Buffer PBI without the
PCR sample). If the color of the mixture is orange or violet, add 10 μl of 3 M
sodium acetate, pH 5.0, and mix. The color of the mixture will turn to yellow.
3. Place a QIAquick spin column in a provided 2 ml collection tube.
4. To bind DNA, apply the sample to the QIAquick column and centrifuge at
13,000 RPM (~16,000 x g) for 30–60 seconds
5. Discard flow-through. Place the QIAquick column back into the same tube.
Collection tubes are re-used to reduce plastic waste.
6. To wash, add 0.75 ml Buffer PE to the QIAquick column and centrifuge at
13,000 RPM (~16,000 x g) for 30–60 seconds
7. Discard flow-through and place the QIAquick column back in the same tube.
Centrifuge at 13,000 RPM (~16,000 x g)the column for an additional 1 min.
8. Place QIAquick column in a clean 1.5 ml microcentrifuge tube.
9. To elute DNA, add 50 μl ddH20 to the center of the QIAquick membrane and
centrifuge the column at 13,000 RPM (~16,000 x g) for 1 minute.
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IMPORTANT: Ensure that the elution buffer is dispensed directly onto the
QIAquick membrane for complete elution of bound DNA.
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Appendix F
Digestion of tri101 from PCR amplified pUCSVtri101
using Bam HI and Hind III
Materials
ddH20
10x Buffer E (Promega R005A, Madison, WI
Amplified, extracted, and purified tri101 (60 ng/ml)
10 units/μL Bam HI (Promega R602A, Madison, WI)
10 units/μL Hind III (Promega R604A, Madison, WI)
1.5 ml Eppendorf Tubes (Fisher 05408129, Atlanta, GA)
Procedure
The digestion was completed using the following reaction:
37 μL distilled, deionized H20 (ddH20)
8 μL of 10x Buffer E (Promega R005A, Madison, WI)
35 μL of amplified, extracted, and purified 60 ng/µl tri101
4 μL of 10 units/μL Bam HI (Promega R602A, Madison, WI)
4 μL of 10 units/μL Hind III (Promega R604A, Madison, WI)
88 μL Total
Solutions were placed into 1.5 ml eppendorf tubes and incubated for 2 hours
in a 37ºC water bath.
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Appendix G1
Ligation of tri101 into pQE30

Materials
Digested (Bam HI, Hind III), purified tri101 gene product (60 µg/ml)
pQE30 (QIAGEN 32915, Valencia, CA)
2x ligation buffer (Promega C6713, Madison, WI)
T4 ligase (Promega, M180a, Madison, WI)
1.5 ml Eppendorf tubes (Fisher 05408129, Atlanta, GA)
Procedures
The reaction consisted of:
•
•
•
•

2 μL of 30 ng/µl pQE30 (QIAGEN 32915, Valencia, CA)
2 μL digested, purified 60 ng/µl tri101 gene product
5 μL of 2x ligation buffer (Promega C6713, Madison, WI)
1 μL of T4 ligase (Promega, M180a, Madison, WI)
10 μL total

and was incubated at room temperature for 2 hours.
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Appendix G2
JM109 Competent Cell Transformation Protocol
Corresponds to Appendix A except for the following changes:

Step 3 Gently mix the thawed Competent Cells by tapping the tube, and transfer
100 µl to the chilled culture tube. (instead of 50 µl in Appendix A)
Step 8 Add 900µl of cold (4°C) SOC medium (instead 950 µl in Appendix A) to
each transformation reaction, and incubate for 90 minutes at 37°C with shaking
(approximately 225rpm).
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Appendix H
PCR was completed to amplify the 4 pQE30 plasmids that
accepted tri101
Appendix D with the following changes:
Use 5 µl of pQEtri101 (instead of pUCSVtri101 in Appendix D) in the reaction
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Appendix I
Digestion of pQEtri101 with Bam HI and Hind III
Appendix F with the following changes:
•
•
•
•
•

13 μL distilled, deionized H20
2 μL of 10x Buffer (Promega R005A, Madison, WI)
5 μL pQEtri101
5 μL Bam HI (Promega R602A, Madison, WI)
5 μL of Hind III (Promega R604A, Madison, WI)
30 μL total
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Appendix J
SDS PAGE
Materials:

Mini Protean Tetra Cell (BioRad 165-8002, Hercules CA)
44 mM Ammonium persulfate (BioRad 161-0700 Hercules, CA)
30 % bisacrylamide (BioRad 161-0436)
0.5 and 1.5 M Tris-HCl (Fisher, BP 153-1 Atlanta, GA)
Isobutanol (Fisher AA36643K7, Atlanta, GA)
1N HCl (Fisher, A485-212 Atlanta, GA)
Tris Base (Fisher, BP 152-5 Atlanta, GA)
Glycine (Fisher BP 381-5 Atlanta, GA)
SDS (Fisher BP 166500 Atlanta, GA)
≥ 99.9% Methanol (Fisher, BP 1105-4 Atlanta, GA)
99.7+% Acetic Acid C2H4O2 (Fisher AC423220025, Atlanta, GA)
β-mercaptolethanol (Fisher BP 176-100 Atlanta, GA)
Commassie Blue R-250 (Fisher BP 161-0400 Atlanta, GA)
TEMED (Fisher BP 150-20 Atlanta, GA)
Loading Tips (Fisher 05408154, Atlanta, GA)
AccuSpin MicroR Microcentrifuge (Fisher 13100511, Atlanta GA)
Alpha Innotek FluorChemTM 5500 (AlphaInnoTek 5500, San Leandro,
CA)

Solutions

44 mM Ammonium persulfate ((NH4)2S2O8; F.W. 228.2)
1g ammonium persulfate
10 mL dd H2O
Aliquot into 0.5 mL fractions and freeze at -20C
Separating gel buffer- 1.5 M Tris-HCl, pH 8.8
27.23 g Tris Base (H2NC(CH2OH)3·HCl; C4H11NO3·HCl; F.W. 157.60)
80 mL dd H2O.
Tritrate with 1N HCl to pH 8.8.
Add dd H20 to desired final volume of 150 mL
Stacking gel buffer 0.5 M Tris-HCl, pH 6.8
6 g Tris Base (H2NC(CH2OH)3·HCl; C4H11NO3·HCl; F.W. 157.60)
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60 mL dd H2O
Tritrate with 1N HCl to pH 6.8
Add dd H20 to desired final volume of 100 ml
10X Running Buffer
Tris Base
30g
Glycine
144 g
SDS
10 g
Add dd H2O to final volume of 1 Liter
To dilute to 1X by adding 900 mL dd H2O to 100 mL 10X Running
Buffer
Staining Solution
Methanol
Acetic Acid
dd H2O
Commassie Blue R-250
Total
Destaining Solution
Methanol
Acetic Acid
dd H2O
Total

500 ml
100 ml
400 ml
2g
1 Liter

500 mL
100 mL
400 mL
1 Liter

2X Loading Buffer
0.5 M Tris-HCl, pH 6.8
Glycerol
10 % SDS
β-mercaptolethanol
Total

2.5 ml
2 ml
4 ml
1 ml
9.5 ml

Water-saturated Isobutanol
Shake equal volumes of water and isobutanol ((CH3)2CHCH2OH;
F.W. 74.12) in a glass bottle
Allow to separate.
Use the top layer.
Store at -4º
Separating Gel
dd H20
1.5% Tris HCl at pH 8.8
10% SDS

3.35 ml
2.5 ml
100 μl
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Acrylamide Bis (30%)
Ammonium Persulfate
TEMED
Total

4.0 ml
40 μl
5 μl
10 ml

Stacking Gel
dd H20
6.1 ml
0.5% Tris HCl at pH 6.8
2.5 ml
10% SDS
100 μl
Acrylamide Bis (30%)
1.3 mL
*Stop at this step (because gel will set so quickly after addition of
Ammonium Sulfate and TEMED, wash the water-saturated
isobutanol off the top of the cassette before adding Ammonium
Persulfate to the solution)
 Decant water saturated
Isobutanol from top of gel cassette
 Rinse cassette with dd H20
at least 3 times
Ammonium Persulfate
40 μL
TEMED
10 μL
Total
10 ml

Procedure

SDS PAGE
1. Prepare 10% Separating Gel
2. Place glass cassette into casting stands
3. Load into glass cassette using 5 mL pipette
a. Fill until about ½ to ¾ inch below top of cassette to account for
stacking gel
4. Add ~ 1mL water saturated isobutanol
5. Ensure no bubbles are present
6. Allow get to set for 45 minutes
7. Prepare stacking gel
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8. Add ~ 1 mL stacking gel to glass cassette to fill
9. Ensure no bubbles are present
10. Push comb into place
11. Let stacking gel set for 45 minutes
12. Meanwhile prepare samples for loading
13. Remove samples containing 2X loading buffer from -20C freezer
14. Place in floater
15. Boil for 5 minutes
16. Microcentrifuge for 10 seconds 13,000 RPM (~16,000 x g)
17. Remove glass cassettes from the gel casting stands
18. Place glass cassettes into casting frames
19. Place casting frames with glass cassettes in electrode apparatus
20. Fill portion between glass cassettes almost full with Running Buffer
a. Ensure to fill to above beginning of gel portion, but below top of
cassette
21. Add running buffer to running apparatus to fill it ~ 1/3 full
22. Remove gel comb
23. Using loading tips, 10 μL of each sample was loaded into each lane
24. Place the lid on the apparatus by positioning the positive (red) electrodes
together and the negative (black) electrodes together
25. Set machine to 200 volts for 45 minutes at 3.0 Amps
26. Push start
27. Wait 45 minutes
28. Remove glass cassette
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29. Decant running buffer
30. Separate the glass cassettes using plastic spatula
31. While gel is still attached to one piece of glass, cut off stacking gel portion
with the spatula
32. Place gel into staining solution and shake for 1 hour at room temperature
33. Move gel to destaining solution and shake for 1 hour at room temperature
34. Move gel to distilled H20 overnight at room temperature
35. Take picture of gel using fluorescent filter of FluorChem 5500
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Appendix K
Purification of tri101 from inclusion bodies
Materials
5M NaCl (Fisher BP305-212 Atlanta, GA)
1M Imidazole (Fisher BP305-50 Atlanta, GA)
50 mM Sodium Phosphate (Fisher BP 330-1 Atlanta, GA)
6 M HCl (Fisher SA48-1 Atlanta, GA)
10% Glycerol (Fisher BP 229-1 Atlanta, GA)
30% Empigen BB Detergent (Calbiochemical 324690, San Diego, CA)
LB Broth (Fisher BP1426-500 Atlanta, GA)
LB Agar (Fisher BP1425-500 Atlanta, GA)
50 mg/ml Ampicillin (Sigma A0166-5G, St Louis, MO)
JM109 Competent Cells (Promega L2001 Madison, WI)
Ni-NTA Agarose (Qiagen 30230 Valencia, CA)
5 mL Polypropylene Columns (Qiagen 34964 Valencia, CA)
β-mercaptolethanol (Fisher BP 176-100 Atlanta, GA)
500 ml Centrifuge bottle (Fisher 14-375-355, Atlanta GA)
Distilled, deionized water
Isopropyl β-D-thiogalactopyranoside (IPTG; Sigma, I5502-1G St Louis,
MO)
10X PBS (Sigma P5493, St Louis, MO)
10 mg/ml Lysozyme (Sigma L3790, St Louis, MO)
Innoculating loops (Fisher 13-075-2 Atlanta, GA)
Beckman Centrifuge (Beckman Coulter J2-HS, Fullerton, CA)
Jouan Centrifuge (ThermoScientific CR312, Atlanta, GA)
Sonic Dismembrator (Fisher 1533853, Atlanta GA)
1.5 ml Eppendorf tubes (Fisher 05408129, Atlanta, GA)
15 ml Graduated Tubes Fisher 05-538-59B, Atlanta, GA)
Falcon 5 ml Polysterene Round Bottom Tubes (Fisher 14-959-1A,
Atlanta, GA)
100 O.D. x 15mm H Petri Dishes (Fisher 0875712, Atlanta, GA)
Isotemp Refridgerator (Fisher 13-986-106A, Atlanta GA)
5.7 x 93.5 mm 30 ml Nalgene Polypropylene Centrifuge Tubes (Fisher
5291C, Atlanta, GA)
Solutions

1X PBS
Dilute 1 part 10X PBS with 10 parts ddH20
LB Broth
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500 mL dd H20
12.5 g LB Broth (powder)
Autoclave for 20 minutes
Cool to 55ºC
Add 1 ml of 50 μg/mL Ampicillin
LB Agar plates
500 mL dd H20
20 g LB Agar
Autoclave for 20 minutes
Cool to 55ºC
Add 1 ml of 50 mg/mL Ampicillin
Pour plates
IPTG (100 mM)
40 mL dd H20
Add 1.19 g isopropyl β-D-thiogalactopyranoside
Adjust volume to 50 ml with dd H20
Divide in 5 ml aliquots and sterilize by filtration with 0.2 µm filter unit
Store at -20ºC (stable for 2-4 months)
Lysis buffer
50 mM Sodium Phosphate (NaH2PO4 · H2O; F.W. 137.99)
300 mM NaCL (NaCl; F.W. 58.44)
20 mM Imidazole (HNCH:CHN:CH; C3H4N2; F.W. 68.08)
Add Deionized, dd H20to bring to desired volume
Adjust pH to 8.0 using 6M HCl
Store at 4ºC
Wash Buffer
50 mM Sodium Phosphate (NaH2PO4 · H2O; F.W. 137.99)
300 mM NaCL (NaCl; F.W. 58.44)
20 mM Imidazole (HNCH:CHN:CH; C3H4N2; F.W. 68.08)
10 % (of desired final volume) glycerol
Add dd H20 to bring to desired volume
Adjust pH to 8.0 using 6M HCl
Store at 4ºC
Elution Buffer
50 mM Sodium Phosphate (NaH2PO4 · H2O; F.W. 137.99)
300 mM NaCL (NaCl; F.W. 58.44)
300 mM Imidazole (HNCH:CHN:CH; C3H4N2; F.W. 68.08)
10% (of desired final volume) glycerol
Add dd H20 to bring to desired volume
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Adjust pH to 8.0 using 6M HCl
Store at 4ºC
2x Loading Buffer
2.5 ml of 0.5 M Tris HCl (pH 6.8)
2 ml of 10% Glycerol
4 ml of 10% SDS
1 ml β-marcaptoethanol
2 mg Bromophenol Blue
0.5 ml dd H20
Procedure

Inoculation
1. Using a plastic inoculation loop, choose a single colony of
JM109/pQEtri101 from the LB plus Ampicillin agar plate
2. Inoculate colony into 5mL LB Broth with ampillicin (final concentration of
100 µg/ml)
3. Incubate overnight at 37ºC in a shaking water bath
Induction
4. Pour overnight culture into 50 mL prewarmed (37ºC) LB Ampicillin (final
concentration of 100 µg/ml) media
5. Incubate culture at 37ºC for 3 hours in a shaking water bath
6. After 3 hours, check the OD using 1 mL of culture media. Use LB media
as the blank. Continue incubation at 37°C until OD ≥0.5
7. Remove 2 “pre-induction” 1 mL samples
a. Microcentrifuge for 1 minute at 13,000 RPM (~16,000 x g)
b. Pour off supernant
c. Resuspend pellet in 50 μL 2X loading buffer
d. Store at -20ºC until SDS PAGE
8. Add 2 mM IPTG (1 mL) to the remaining culture
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9. Incubate at 37ºC for 3 hours in a shaking water bath
10. After 3 hours, remove 2 - 1mL “post induction” samples
a. MicroCentrifuge for 1 minute at 13,000 RPM (~16,000 x g)
b. Pour off supernant
c. Resuspend pellet in 50 μL 2X loading buffer
d. Store at -20ºC until SDS PAGE
11. Pour remaining induced culture into 2 centrifuge bottles of equal volumes
12. Centrifuged at 4ºC at 5,000 RPM for 20 minutes (3836 x g) using the
Beckman Centrifuge
13. Pour off supernant
14. Resuspended 1st pellet using 5 mL 1X PBS (room temperature). Be sure
pellet is resuspended completely. Wash sides of centrifuge bottle.
Transfer complete solution to the second bottle
15. Resuspend 2nd pellet using same 5mL 1X PBS suspension from bottle one
16. Transfer to 5 ml Polysterene Round Bottom Tube
17. Add 100 μL lysozyme at 50 mg/mL (final concentration 1mg/ml lysozyme)
18. Place on ice for 30 minutes
19. Meanwhile prepared ice/NaCl adding about 100 grams of NaCl to a 200
ml flask full of ice (this will keep solution extra cold during sonication)
20. Remove suspension from ice and place tube into Ice/NaCl mixture to keep
cold
Sonication
21. Position sonicator probe into suspension so that it is submerged at least ½
inch, ensuring that probe does not touch sides or bottom of tube
22. Sonicate at level 3 for 1 minute
23. Rest for 2 minutes
24. Repeat 4 times (5 total)
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25. Transfer solution to 30 ml polypropylene centrifuge tube
26. Centrifuge for 30 minutes at 4ºC at 10,000 RPM (15,344 x g) in the
Beckman Centrifuge
Ni NTA Column
27. The supernant from centrifugication in step 26,
a. Label tube “Soluable”
i. Remove 50 µl for SDS PAGE
ii. Mix with 50 µl of 2x loading buffer
b. place in -20ºC freezer
28. Resuspend pellet from step 26, in 5 mL lysis buffer
a. Label as “INSoluable”
i. Remove 100 µl for SDS PAGE
ii. Microcentrifuge for 1 minute at 13,000 RPM (16,000 x g)
iii. Resuspend pellet in 50 µl of 2x loading buffer
29. Add 0.5 mL of 30% Empigen to the insoluable sample or pellet fraction
30. Placed on rocker in 4ºC Isotemp refrigerator overnight
31. The next morning, aliquot into 1 mL fractions and place in 1.5 ml
microcentrifuge tubes
32. Microcentrifuge for 20 minutes at 13,000 RPM (~16,000 x g)
33. Meanwhile, pre-equilibrate Ni NTA Agarose using Lysis buffer
a. Combine 1 mL Ni NTA Agarose with ~ 5mL Lysis buffer
b. Centrifuge at 3000 for 1 minute (~1296 x g)
c. Withdraw majority of supernant with pastuer pipette and discard (do
NOT decant supernant, because agarose will pour out too)
d. Repeat 2 additional times (3 total)
34. After microcentrifugication of insoluabe fraction is complete, there should
be no pellet. Pipett all supernant into pre-equilibrated 1 ml Ni NTA
solution
35. Place on rocking platforrm and mix for 1.5 hours in 4ºC
36. Label 1 mL tubes for elution 1 to 5, wash 1 to 5, and a larger tube for flow
through
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37. Label 11 1.5 mL tubes for SDS PAGE samples the same as Step 36.
Place 50 μL 2X loading buffer in each tube plus (elution fractons 1-5, wash
fractions 1-5, and flow through)
38. Aliquot 2.5 mL of Elution and Wash buffer into separate, labeled tubes
39. Fill column with lysis buffer
40. Remove tip from column and drain majority of lysis buffer from column.
Replace tip when finished. Discard lysis buffer
41. Remove insoluable fraction from rocker
42. Pour the sample with Ni-NTA agarose into column
43. Allow column to settle
a. Ni-Nta agarose will settle to bottom of the column
b. The lysis buffer and insoluable fraction will float to top
44. Remove tip and collect flow through (Don’t allow all of the lysis buffer
solution to drain off. Leave a small amount, between .25 and .5 ml, above
the agarose)
45. Add 1 mL Wash buffer
a. Collect 0.3 mL fractions in each of the 5 1 mL centrifuge tubes
b. Add rest of wash buffer as needed
c. Don’t allow the column all of the wash buffer solution to drain off.
Leave a small amount, between .25 and .5 ml, above the agarose
46. Repeat step 45 with 2.5 ml of the aliquoted Elution buffer to acquire the
isolated protein, rrTri101
47. Pipette 50 μL from each elution, wash, and flow through fraction tubes and
place in corresponding labeled tubes with 2X loading buffer (Step 37)
48. Store remaining sample tubes at -20ºC until completing SDS PAGE
49. Run SDS PAGE (Appendix J) on samples from the pre-induced sample,
the post induction sample, the supernant or soluable sample, the pellet or
insoluable sample, the flow through, each of the 5 wash fractions, and
each of the 5 eluted fractions.
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Appendix L
Pierce Slide-A-Lyzer® Dialysis

Materials

Slide-A-Lyzer Dialysis Cassettes (Pierce 66370, Rockford, IL )
Slide-A-Lyzer Buoys (Pierce 66430 Rockford, IL)
Slide-A-Lyzer Syringe (5 ml) and 18 Gauge Needle Accessories
(Pierce 66490 Rockford, IL)
10X PBS (Sigma P5493, St Louis, MO)

Solutions

1X PBS
Dilute 1 part 10X PBS with 10 parts ddH20
Procedure

1. Thaw rTri101 on ice
2. Remove the Slide-A-Lyzer Dialysis Cassette from its protective pouch by
cutting along the dotted line.
3. Attach the hub of a hypodermic needle to the Luer-Lok® Fitting of the
syringe by firmly screwing it into place.
4. Remove the protective sheath from the hypodermic needle and filled
syringe with rTri101 IB sample by immersing the needle in the sample and
then slowly drawing back on the syringe piston.
5. Remove cassette from the buoy. Penetrate gasket through one of the
syringe ports at a corner of the cassette with the needle and inject sample.
Mark the cassette corner with a permanent marker.
6. With the needle still inserted in the cassette cavity, draw up on the piston
to remove air from the cavity to compress the membrane so the sample
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contacts the greatest membrane surface area. Use caution to prevent the
needle from contacting the membrane.
7. Remove the syringe needle from the cassette while retaining the air in the
syringe. The gasket reseals and the membrane cavity has no (or minimal)
air in direct contact with the sample.
8. Slip the cassette into the groove of a buoy and float this assembly in a
beaker containing 800 ml of 1X PBS to dialyze:
a.
b.
c.
d.

Dialyze for 2 hours in 1X PBS at 4°C;
Change the 1X PBS and dialyze for another 2 hours at 4°C;
Change the 1X PBS and dialyze overnight at 4°C.
Use the 800 ml of 1X PBS for each buffer

9. To remove sample, fill syringe with a volume of air at least equal to the
sample size.
10. Penetrate the gasket with a needle through a top, unused syringe guide
port. Discharge air into cassette cavity to separate membranes, which
prevents needle penetration of the membrane.
11. Rotate the Cassette until the port with the syringe is on the bottom and
slowly draw back on the syringe piston to capture the dialyzed sample.
Remove the syringe needle from the cassette. Discard the Slide-A-Lyzer
Dialysis Cassette.
12. Store samples as -20°C until ready for BCA protein assay.
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Appendix M
Pierce BCA Protein Assay
Materials

Glass tubes (Fisher 14-961-26 Atlanta, GA)
Smart Spec 3000 Spectrophotometer (Biorad, 170-2501EDU)
BCA Protein Assay Kit (Pierce 23225, Rockford, IL) contained:
BCA Reagent A, contained: sodium carbonate, sodium bicarbonate,
bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide
BCA Reagent B, contained 4% cupric sulfate
Albumin Standard Ampules, 2 mg/ml, 10 - 1 ml ampules, containing
bovine serum albumin (BSA) at 2.0 mg/ml in 0.9% saline and 0.05%
sodium azide
Procedure:

Preparation of Standards and Working Reagent
A. Preparation of Diluted Albumin (BSA) Standards
Use Appendix Table 2.1 as a guide to prepare a set of protein standards.
Use dd H20 to dilute the contents of one Albumin Standard (BSA) ampule
into several clean vials, preferably using the same diluent as the
sample(s). There will be sufficient volume for three replications of each
diluted standard.
B. Preparation of the BCA Working Reagent (WR)
1. Use the following formula to determine the total volume of WR required:
(# standards + # unknowns) × (# replicates) × (volume of WR per sample) = total
volume WR required
Example: for the standard test-tube procedure with 3 unknowns and 2 replicates
of each sample:
(9 standards + 3 unknowns) × (2 replicates) × (2 ml) = 48 ml WR required
2. Prepare WR by mixing 50 parts of BCA Reagent A with 1 part of BCA Reagent
B (50:1, Reagent A:B). For the above example, combine 50 ml of Reagent A with
1 ml of Reagent B.
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Appendix Table 2.1 Preparation of Diluted Albumin (BSA) Standards
Dilution Scheme for Standard Test Tube Protocol and Microplate Procedure
(Working Range = 20–2,000 μg/ml)
Vial

A
B
C

Volume
distilled,
deionized
H20
(μL)
0
125
325

D

175

E

325

F

325

G

325

H
I

400
400

Volume & Source

Final BSA

of BSA
(μL)
300 μL Stock
375 μL Stock
325 μL Stock
175 μL vial B
dilution
325 μL vial C
dilution
325 μL vial E
dilution
325 μL vial F
dilution
100 μL vial G
dilution
0

Concentration
(µg/mL)
2000
1500
1000
750
500
250
125
25
Blank

Note: When Reagent B is first added to Reagent A, turbidity is observed that
quickly disappears upon mixing to yield a clear, green WR. Prepare sufficient
volume of WR based on the number of samples to be assayed. The WR is stable
for several days when stored in a closed container at room temperature (RT).
Procedure Summary
1. Pipette 0.1 ml of each standard and unknown sample replicate into an
appropriately labeled test tube.
2. Add 2.0 ml of the WR to each tube and mix well.
3. Cover and incubate tubes at selected temperature and time:
• 37°C for 30 minutes (working range = 20-2,000 μg/ml)
4. Cool all tubes to room temperature
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5. With the spectrophotometer set to 562 nm, zero the instrument on a cuvette
filled only with water. Subsequently, measure the absorbance of all the samples
within 10 minutes.
6. Subtract the average 562 nm absorbance measurement of the Blank standard
replicates from the 562 nm absorbance measurement of all other individual
standard and unknown sample replicates.
7. Prepare a standard curve by plotting the average Blank-corrected 562 nm
measurement for each BSA standard vs. its concentration in μg/ml. Use the
standard curve to determine the protein concentration of each unknown sample.
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Appendix N
Purification of rTri101 from soluble fractions
Use materials and solutions recipes from Appendix K with the following changes
to the procedure:
Procedure
Inoculation
1. Using a plastic inoculation loop, choose a single colony of
JM109/pQEtri101 from the LB plus Ampicillin agar plate
2. Inoculate colony into 5mL LB Broth with ampillicin (final concentration of
100 µg/ml)
3. Incubate overnight at 37ºC in a shaking water bath
Induction
4. Inoculate overnight culture into 50 mL prewarmed (37ºC) LB Ampicillin
(final concentration of 100 µg/ml) media
5. Incubate culture at 37ºC for 3 hours in a shaking water bath
6. After 3 hours, check the OD using 1 mL of culture media. Use LB media
as the blank. Continue incubation at 37°C until OD ≥0.5
7. Remove 2 “pre-induction” 1 mL samples
a. Microcentrifuge for 1 minute at 13,000 RPM (~16,000 x g)
b. Pour off supernant
c. Resuspend pellet in 50 μL 2X loading buffer
d. Store at -20ºC until SDS PAGE
8. Add 1 mM IPTG (0.5 mL) to the remaining culture
9. Incubate at 37ºC for 2 hours in a shaking water bath
10. After 2 hours, remove 2 - 1mL “post induction” samples
a. MicroCentrifuge for 1 minute at 13,000 RPM (~16,000 x g)
b. Pour off supernant
133

c. Resuspend pellet in 50 μL 2X loading buffer
d. Store at -20ºC until SDS PAGE
11. Pour remaining induced culture into 2 centrifuge bottles of equal volumes
12. Centrifuged at 4ºC at 5,000 RPM for 20 minutes (3836 x g) using the
Beckman Centrifuge
13. Pour off supernant
14. Resuspended 1st pellet using 5 mL 1X PBS (room temperature). Be sure
pellet is resuspended completely. Wash sides of centrifuge bottle.
Transfer complete solution to the second bottle
15. Resuspend 2nd pellet using same 5mL 1X PBS suspension from bottle one
16. Transfer to 5 ml Polysterene Round Bottom Tube
17. Place on ice for 30 minutes (do not add any lysozyme)
18. Meanwhile prepared ice/NaCl adding about 100 grams of NaCl to a 200
ml flask full of ice (this will keep solution extra coldl during sonication)
19. Remove suspension from ice and place tube into Ice/NaCl mixture to keep
cold
Sonication
20. Position sonicator probe into suspension so that it is submerged at least
½ inch, ensuring that probe does not touch sides or bottom of tube
21. Sonicate at level 3 for 1 minute
22. Rest for 2 minutes
23. Repeat 4 times (5 total)
24. Transfer solution to 30 ml polypropylene centrifuge tube
25. Centrifuge for 30 minutes at 4ºC at 10,000 RPM (15,344 x g) in the
Beckman Centrifuge
26. For the supernant from centrifugication in step 25,
a. Label tube “Soluable”
i. Remove 50 µl for SDS PAGE
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ii. Mix with 50 µl of 2x loading buffer
27. For the pellet from step 25,
a. Resuspend pellet in 5 mL lysis buffer
b. Label as “INSoluable”
i. Remove 100 µl for SDS PAGE
ii. Microcentrifuge for 1 minute at 13,000 RPM (16,000 x g)
iii. Resuspend pellet in 50 µl of 2x loading buffer
c. Store in -20ºC freezer
Ni NTA Column
28. Thaw supernant (soluble fraction) on ice
29. Aliquot into 1 mL fractions and place in 1.5 ml microcentrifuge tubes
30. Microcentrifuge for 20 minutes at 13,000 RPM (~16,000 x g)
31. Meanwhile, pre-equilibrate Ni NTA Agarose using Lysis buffer
a. Combine 1 mL Ni NTA Agarose with ~ 5mL Lysis buffer
b. Centrifuge at 3000 for 1 minute (~1296 x g)
c. Withdraw majority of supernant with pastuer pipette and discard (do
NOT decant supernant, because agarose will pour out too)
d. Repeat 2 additional times (3 total)
32. After microcentrifugation of soluble fraction is complete, there should be
no pellet. Pipette all supernant into pre-equilibrated 1 ml Ni NTA solution
33. Place on rocking platform and mix for 1.5 hours in 4ºC
34. Label 1 mL tubes for elution 1 to 5, wash 1 to 5, and a larger, 15 ml tube
for flow through
35. Label 11 1.5 mL tubes for SDS PAGE samples the same as step 34.
Place 50 μL 2X loading buffer in each tube plus (elution fractions 1-5,
wash fractions 1-5, and flow through)
36. Aliquot 2.5 mL of Elution and Wash buffer into separate, labeled tubes
37. Fill column with lysis buffer
38. Remove tip from column and drain majority of lysis buffer from column.
Replace tip when finished. Discard lysis buffer
39. Remove soluble fraction with Ni-NTA agarose from rocker
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40. Pour the sample with Ni-NTA agarose into column
41. Allow column to settle (wait 1 to 3 minutes)
a. Ni-NTA agarose will settle to bottom of the column
b. The lysis buffer and soluable fraction will float to top
42. Remove tip and collect flow through (Don’t allow all of the lysis buffer
solution to drain off. Leave a small amount, between .25 and .5 ml, above
the agarose)
43. Add 1 mL Wash buffer
a. Collect 0.3 mL fractions in each of the 5 1 mL centrifuge tubes
b. Add rest of wash buffer as needed
c. Don’t allow the column all of the wash buffer solution to drain off.
Leave a small amount, between .25 and .5 ml, above the agarose
44. Repeat step 43 with 2.5 ml of the aliquoted Elution buffer to acquire the
isolated protein, rrTri101
45. Pipette 50 μL from each elution, wash, and flow through fraction tubes and
place in corresponding labeled tubes with 2X loading buffer (Step 35)
46. Store remaining sample tubes at -20ºC until completing SDS PAGE
47. Run SDS PAGE (Appendix J) on samples from the pre-induced sample,
the post induction sample, the supernant or soluable sample, the pellet or
insoluable sample, the flow through, each of the 5 wash fractions, and
each of the 5 eluted fractions.
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Appendix O
Production of Crude rTri101
Use materials and solutions recipes from Appendix K with the following changes
to the procedure:
Inoculation
1. Using a plastic inoculation loop, choose a single colony of
JM109/pQEtri101 from the LB plus Ampicillin agar plate
2. Inoculate colony into 5mL LB Broth with ampillicin (final concentration of
100 µg/ml)
3. Incubate overnight at 37ºC in a shaking water bath
Induction
4. Inoculated overnight culture into 50 mL prewarmed (37ºC) LB Ampicillin
(final concentration of 100 µg/ml) media
5. Incubate culture at 37ºC for 3 hours in a shaking water bath
6. After 3 hours, check the OD using 1 mL of culture media. Use LB media
as the blank. Continue incubation at 37°C until OD ≥0.5
7. Remove 2 “pre-induction” 1 mL samples
a. Microcentrifuge for 1 minute at 13,000 RPM (~16,000 x g)
b. Pour off supernant
c. Resuspend pellet in 50 μL 2X loading buffer
d. Store at -20ºC until SDS PAGE
8. Add 1 mM IPTG (0.5 mL) to the remaining culture
9. Incubate at 37ºC for 2 hours in a shaking water bath
10. After 2 hours, remove 2 - 1mL “post induction” samples
a. MicroCentrifuge for 1 minute at 13,000 RPM (~16,000 x g)
b. Pour off supernant
c. Resuspend pellet in 50 μL 2X loading buffer
d. Store at -20ºC until SDS PAGE
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11. Pour remaining induced culture into 2 centrifuge bottles of equal volumes
12. Centrifuged at 4ºC at 5,000 RPM for 20 minutes (3836 x g) using the
Beckman Centrifuge
13. Pour off supernant
14. Resuspended 1st pellet using 5 mL 1X PBS (room temperature). Be sure
pellet is resuspended completely. Wash sides of centrifuge bottle.
Transfer complete solution to the second bottle
15. Resuspend 2nd pellet using same 5mL 1X PBS suspension from bottle one
16. Transfer to 5 ml Polysterene Round Bottom Tube
17. Add 100 μL lysozyme at 50 mg/mL (final concentration 1mg/ml lysozyme)
18. Place on ice for 30 minutes
19. Meanwhile prepared ice/NaCl adding about 100 grams of NaCl to a 200
ml flask full of ice (this will keep solution extra coldl during sonication)
20. Remove suspension from ice and place tube into Ice/NaCl mixture to keep
cold
Sonication
21. Position sonicator probe into suspension so that it is submerged at least ½
inch, ensuring that probe does not touch sides or bottom of tube
22. Sonicate at level 3 for 1 minute
23. Rest for 2 minutes
24. Repeat 4 times (5 total)
25. Transfer solution to 30 ml polypropylene centrifuge tube
26. Centrifuge for 30 minutes at 4ºC at 10,000 RPM (15,344 x g) in the
Beckman Centrifuge
27. The supernant from centrifugication in step 26,
a. Label tube “Soluable”
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i. Remove 50 µl for SDS PAGE
ii. Mix with 50 µl of 2x loading buffer
b. place in -20ºC freezer
28. Resuspend pellet from step 26, in 5 mL lysis buffer
a. Label as “INSoluable”
i. Remove 100 µl for SDS PAGE
ii. Microcentrifuge for 1 minute at 13,000 RPM (16,000 x g)
iii. Resuspend pellet in 50 µl of 2x loading buffer
29. Store remaining sample tubes at -20ºC until completing SDS PAGE
30. Run SDS PAGE (Appendix J) on samples from the pre-induced sample,
the post induction sample, the supernant or soluable sample, and the
pellet or insoluable sample.
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